[go: up one dir, main page]

TWI856950B - Heterocyclic compound and organic light emitting device comprising the same - Google Patents

Heterocyclic compound and organic light emitting device comprising the same Download PDF

Info

Publication number
TWI856950B
TWI856950B TW107134589A TW107134589A TWI856950B TW I856950 B TWI856950 B TW I856950B TW 107134589 A TW107134589 A TW 107134589A TW 107134589 A TW107134589 A TW 107134589A TW I856950 B TWI856950 B TW I856950B
Authority
TW
Taiwan
Prior art keywords
substituted
unsubstituted
group
layer
organic light
Prior art date
Application number
TW107134589A
Other languages
Chinese (zh)
Other versions
TW202024299A (en
Inventor
李允智
吳韓國
池慧秀
鄭元場
崔珍碩
崔大赫
Original Assignee
南韓商Lt素材股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南韓商Lt素材股份有限公司 filed Critical 南韓商Lt素材股份有限公司
Priority to TW107134589A priority Critical patent/TWI856950B/en
Publication of TW202024299A publication Critical patent/TW202024299A/en
Application granted granted Critical
Publication of TWI856950B publication Critical patent/TWI856950B/en

Links

Images

Landscapes

  • Electroluminescent Light Sources (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present specification relates to a heterocyclic compound represented by chemical formula 1, and an organic light emitting device comprising the same.
[Chemical Formula 1]
Figure 107134589-A0305-02-0002-193
In Chemical Formula 1, the definition of each substituents is the same as in detail description.

Description

雜環化合物與包含其的有機發光裝置 Heterocyclic compounds and organic light-emitting devices containing the same

本說明書是關於雜環化合物及包括其的有機發光裝置。 This specification relates to heterocyclic compounds and organic light-emitting devices containing the same.

電致發光裝置為一類自動發光顯示裝置,且具有優勢,所述優勢為具有廣視角以及較快回應速度且具有極佳對比度。 Electroluminescent devices are a type of self-luminous display device and have the advantages of wide viewing angles, fast response speeds, and excellent contrast.

有機發光裝置具有在兩個電極之間安置有機薄膜之結構。當將電壓施加至具有此類結構之有機發光裝置時,自兩個電極注入之電子及電洞在有機薄膜中結合及配對,且在所述電子及所述電洞湮滅時發光。視需要可形成單層或多層有機薄膜。 An organic light-emitting device has a structure in which an organic thin film is disposed between two electrodes. When a voltage is applied to an organic light-emitting device having such a structure, electrons and holes injected from the two electrodes are combined and paired in the organic thin film, and light is emitted when the electrons and the holes are annihilated. A single layer or multiple layers of organic thin films can be formed as needed.

視需要,有機薄膜之材料可具有發光功能。舉例而言,可單獨使用能夠形成發光層本身的化合物作為有機薄膜的材料,或亦可使用能夠起到主體-摻雜劑類(host-dopant-based)發光層的主體或摻雜劑作用的化合物作為有機薄膜的材料。另外,亦可使用能夠起電洞注入、電洞轉移、電子阻擋、電洞阻擋、電子轉移、電子注入以及類似作用之化合物作為有機薄膜的材料。 If necessary, the material of the organic thin film may have a light-emitting function. For example, a compound that can form a light-emitting layer itself can be used alone as a material for the organic thin film, or a compound that can play the role of a host or dopant of a host-dopant-based light-emitting layer can be used as a material for the organic thin film. In addition, compounds that can play the role of hole injection, hole transfer, electron blocking, hole blocking, electron transfer, electron injection and the like can also be used as materials for the organic thin film.

有機薄膜材料的發展不斷要求提昇有機發光裝置之效能、壽命或效率。 The development of organic thin film materials continues to require the improvement of the performance, life or efficiency of organic light-emitting devices.

[現有技術文件] [Existing technical documents]

[專利文件] [Patent Documents]

美國專利第4,356,429號 U.S. Patent No. 4,356,429

本發明是有關於提供新穎的雜環化合物及包括其的有機發光裝置。 The present invention relates to providing novel heterocyclic compounds and organic light-emitting devices comprising the same.

本申請案的一個實施例提供由以下化學式1表示的雜環化合物。 One embodiment of the present application provides a heterocyclic compound represented by the following chemical formula 1.

Figure 107134589-A0305-02-0005-5
Figure 107134589-A0305-02-0005-5

在化學式1中,R2至R5彼此相同或不同,且各自獨立地是由下列各者所構成的族群中選出:氫、氘、鹵基、-CN、經取代或未經取代之烷基、經取代或未經取代之烯基、經取代或未經取代之炔基、經取代或未經取代之烷氧基、經取代或未經取代之環烷基、經取代或未經 取代之雜環烷基、經取代或未經取代之芳基、經取代或未經取代之雜芳基、-SiRR'R"、-P(=O)RR'以及胺基,所述胺基未經取代或經以下取代:經取代或未經取代之烷基、經取代或未經取代之芳基或者經取代或未經取代之雜芳基;或彼此相鄰之兩個或更多個基團彼此鍵結以形成經取代或未經取代之脂族或芳族烴環,Ra為氫;經取代或未經取代的烷基;經取代或未經取代的芳基;或經取代或未經取代的雜芳基,Ar1由-(L1)p-(Z1)q表示,Ar2由-(L2)r-(Z2)s表示,L1及L2彼此相同或不同,且各自獨立地為經取代或未經取代之伸芳基;或經取代或未經取代之伸雜芳基,Z1及Z2彼此相同或不同,且各自獨立地是由下列各者所構成的族群中選出:氫、氘、鹵基、-CN、經取代或未經取代之烷基、經取代或未經取代之烯基、經取代或未經取代之炔基、經取代或未經取代之烷氧基、經取代或未經取代之環烷基、經取代或未經取代之雜環烷基、經取代或未經取代之芳基、經取代或未經取代之雜芳基、-SiRR'R"、-P(=O)RR'以及胺基,所述胺基未經取代或經以下取代:經取代或未經取代之烷基、經取代或未經取代之芳基或者經取代或未經取代之雜芳基,R、R'及R"彼此相同或不同,且各自獨立地為氫、氘、-CN、經取代或未經取代之烷基、經取代或未經取代之環烷基、經取代或未經取代之芳基或者經取代或未經取代之雜芳基,p及r為1至4之整數,q及s為1至3之整數,且 n為0至4之整數。 In Formula 1, R2 to R5 are the same as or different from each other and are independently selected from the group consisting of hydrogen, deuterium, halogen, -CN, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, -S iRR'R", -P(=O)RR' and an amine group, the amine group is unsubstituted or substituted by: a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group; or two or more adjacent groups are bonded to each other to form a substituted or unsubstituted aliphatic or aromatic hydrocarbon ring, Ra is hydrogen; a substituted or unsubstituted alkyl group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group, Ar 1 is represented by -(L1)p-(Z1)q, Ar 2 is represented by -(L2)r-(Z2)s, L1 and L2 are the same or different and are each independently a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group, Z1 and Z2 are the same or different and are each independently selected from the group consisting of hydrogen, deuterium, halogen, -CN, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, a substituted or unsubstituted heteroaryl group, -SiRR'R", -P(=O)RR' and an amine group, wherein the amine group is unsubstituted or substituted with a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group, R, R' and R" are the same as or different from each other and are each independently hydrogen, deuterium, -CN, a substituted or unsubstituted alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group, p and r are integers from 1 to 4, q and s are integers from 1 to 3, and n is an integer from 0 to 4.

本申請案的另一實施例提供有機發光裝置,所述有機發光裝置包括:第一電極;第二電極,其設置為與第一電極相對;以及一或多個有機材料層,其設置於第一電極與第二電極之間,其中有機材料層的一或多個層包括根據本發明之一個實施例的雜環化合物。 Another embodiment of the present application provides an organic light-emitting device, the organic light-emitting device comprising: a first electrode; a second electrode disposed opposite to the first electrode; and one or more organic material layers disposed between the first electrode and the second electrode, wherein one or more layers of the organic material layer include a heterocyclic compound according to one embodiment of the present invention.

本說明書中所描述的化合物可用作有機發光裝置的有機材料層材料。化合物能夠在有機發光裝置中起電洞注入材料、電洞轉移材料、發光材料、電子轉移材料、電子注入材料以及類似物的作用。特定言之,可使用化合物作為有機發光裝置之電子轉移層材料、電洞阻擋層材料或電荷產生層材料。 The compounds described in this specification can be used as organic material layer materials of organic light-emitting devices. The compounds can function as hole injection materials, hole transfer materials, light-emitting materials, electron transfer materials, electron injection materials, and the like in organic light-emitting devices. Specifically, the compounds can be used as electron transfer layer materials, hole blocking layer materials, or charge generation layer materials of organic light-emitting devices.

具體而言,當在有機材料層中使用由化學式1表示之化合物時,在裝置中驅動電壓降低且光效率增強,且裝置壽命特性可藉由化合物之熱穩定性增強。 Specifically, when the compound represented by Chemical Formula 1 is used in an organic material layer, the driving voltage is reduced and the light efficiency is enhanced in the device, and the device life characteristics can be enhanced by the thermal stability of the compound.

100:基板 100: Substrate

200:陽極 200: Yang pole

300:有機材料層 300: Organic material layer

301:電洞注入層 301: Hole injection layer

302:電洞轉移層 302: Hole transfer layer

303:發光層 303: Luminous layer

304:電洞阻擋層 304: Hole blocking layer

305:電子轉移層 305:Electron transfer layer

306:電子注入層 306: Electron injection layer

400:陰極 400: cathode

圖1至圖4是各自示意性地繪示出根據本申請案之一個實施例的有機發光裝置之層壓結構的圖。 Figures 1 to 4 are diagrams each schematically illustrating a laminated structure of an organic light-emitting device according to an embodiment of the present application.

在下文中,將詳細地描述本申請案。 Hereinafter, this application will be described in detail.

術語「取代」意謂鍵結至化合物之碳原子的氫原子變為 另一取代基,且取代位置不受限制,只要其為氫原子經取代之位置,亦即取代基可取代之位置,且當兩個或更多個取代基取代時,兩個或更多個取代基可彼此相同或不同。 The term "substitution" means that a hydrogen atom bonded to a carbon atom of a compound is changed to another substituent, and the substitution position is not limited as long as it is a position where a hydrogen atom is substituted, that is, a position where a substituent can be substituted, and when two or more substituents are substituted, the two or more substituents may be the same or different from each other.

在本說明書中,鹵素可為氟、氯、溴或碘。 In this specification, halogen can be fluorine, chlorine, bromine or iodine.

在本說明書中,所述烷基包括具有1至60個碳原子的直鏈或分支鏈,且可進一步經其他取代基取代。烷基之碳原子數可為1至60、具體言之1至40,且更具體言之1至20。其具體實例可包括甲基、乙基、丙基、正丙基、異丙基、丁基、正丁基、異丁基、第三丁基、第二丁基、1-甲基-丁基、1-乙基-丁基、戊基、正戊基、異戊基、新戊基、第三戊基、己基、正己基、1-甲基戊基、2-甲基戊基、4-甲基-2-戊基、3,3-二甲基丁基、2-乙基丁基、庚基、正庚基、1-甲基己基、環戊基甲基、環己基甲基、辛基、正辛基、第三辛基、1-甲基庚基、2-乙基己基、2-丙基戊基、正壬基、2,2-二甲基庚基、1-乙基-丙基、1,1-二甲基-丙基、異己基、2-甲基戊基、4-甲基己基、5-甲基己基以及類似基團,但不限於此。 In the present specification, the alkyl group includes a straight chain or a branched chain having 1 to 60 carbon atoms, and may be further substituted by other substituents. The number of carbon atoms in the alkyl group may be 1 to 60, specifically 1 to 40, and more specifically 1 to 20. Specific examples thereof may include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec-butyl, 1-methyl-butyl, 1-ethyl-butyl, pentyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 4-methyl-2-pentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl, n-heptyl, 1-methylhexyl, cyclopentylmethyl, cyclohexylmethyl, octyl, n-octyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2-dimethylheptyl, 1-ethyl-propyl, 1,1-dimethyl-propyl, isohexyl, 2-methylpentyl, 4-methylhexyl, 5-methylhexyl and the like, but are not limited thereto.

在本說明書中,烯基包括具有2至60個碳原子的直鏈或分支鏈,且可進一步經其他取代基取代。烯基之碳原子數可為2至60、特定言之2至40,且更特定言之2至20。其具體實例可包括乙烯基、1-丙烯基、異丙烯基、1-丁烯基、2-丁烯基、3-丁烯基、1-戊烯基、2-戊烯基、3-戊烯基、3-甲基-1-丁烯基、1,3-丁二烯基、烯丙基、1-苯基乙烯基-1-基、2-苯基乙烯基-1-基、2,2-二苯基乙烯基-1-基、2-苯基-2-(萘基-1-基)乙烯基-1-基、2,2-雙(二苯基-1-基)乙烯基-1-基、芪基(stilbenyl group)、苯乙烯基以及類似基團,但不限於此。 In the present specification, alkenyl includes a straight chain or branched chain having 2 to 60 carbon atoms, and may be further substituted by other substituents. The number of carbon atoms of the alkenyl may be 2 to 60, specifically 2 to 40, and more specifically 2 to 20. Specific examples thereof may include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 3-methyl-1-butenyl, 1,3-butadienyl, allyl, 1-phenylvinyl-1-yl, 2-phenylvinyl-1-yl, 2,2-diphenylvinyl-1-yl, 2-phenyl-2-(naphthyl-1-yl)vinyl-1-yl, 2,2-bis(diphenyl-1-yl)vinyl-1-yl, stilbenyl group, styryl group, and similar groups, but are not limited thereto.

在本說明書中,炔基包括具有2至60個碳原子的直鏈或分支鏈,且可進一步經其他取代基取代。炔基之碳原子數可為2至60、具體言之2至40且更具體言之2至20。 In the present specification, the alkynyl group includes a straight chain or a branched chain having 2 to 60 carbon atoms, and may be further substituted by other substituents. The number of carbon atoms of the alkynyl group may be 2 to 60, specifically 2 to 40, and more specifically 2 to 20.

在本發明中,烷氧基可為直鏈、分支鏈或環狀。烷氧基之碳原子數不受特別限制,但較佳為1至20。其具體實例可包括甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第三丁氧基、第二丁氧基、正戊氧基、新戊氧基、異戊氧基、正己氧基、3,3-二甲基丁氧基、2-乙基丁氧基、正辛氧基、正壬氧基、正癸氧基、苯甲氧基、對甲基苯甲氧基以及類似基團,但不限於此。 In the present invention, the alkoxy group may be a straight chain, a branched chain or a ring. The number of carbon atoms of the alkoxy group is not particularly limited, but is preferably 1 to 20. Specific examples thereof may include methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, neopentoxy, isopentoxy, n-hexoxy, 3,3-dimethylbutoxy, 2-ethylbutoxy, n-octoxy, n-nonyloxy, n-decyloxy, benzyloxy, p-methylbenzyloxy and similar groups, but are not limited thereto.

在本說明書中,環烷基包括具有3至60個碳原子的單環或多環,且可進一步經其他取代基取代。在本文中,多環意謂其中環烷基直接連接至其他環狀基團或與其他環狀基團稠合的基團。在本文中,其他環狀基團可為環烷基,但亦可為不同類型的環狀基團,諸如雜環烷基、芳基以及雜芳基。環烷基之碳基團數可為3至60,具體言之3至40,且更具體言之5至20。其具體實例可包括環丙基、環丁基、環戊基、3-甲基環戊基、2,3-二甲基環戊基、環己基、3-甲基環己基、4-甲基環己基、2,3-二甲基環己基、3,4,5-三甲基環己基、4-第三丁基環己基、環庚基、環辛基以及類似基團,但不限於此。 In the present specification, cycloalkyl includes monocyclic or polycyclic rings having 3 to 60 carbon atoms, and may be further substituted with other substituents. In this article, polycyclic means a group in which the cycloalkyl is directly connected to other cyclic groups or fused to other cyclic groups. In this article, other cyclic groups may be cycloalkyl groups, but may also be different types of cyclic groups, such as heterocycloalkyl, aryl and heteroaryl. The number of carbonyl groups of the cycloalkyl group may be 3 to 60, specifically 3 to 40, and more specifically 5 to 20. Specific examples thereof may include cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, cyclohexyl, 3-methylcyclohexyl, 4-methylcyclohexyl, 2,3-dimethylcyclohexyl, 3,4,5-trimethylcyclohexyl, 4-tert-butylcyclohexyl, cycloheptyl, cyclooctyl and similar groups, but are not limited thereto.

在本說明書中,雜環烷基包括O、S、Se、N或Si作為雜原子,包括具有2至60個碳原子的單環或多環,且可進一步經其他取代基取代。在本文中,多環意謂其中雜環烷基直接連接至其他環狀基團或與其他環狀基團稠合的基團。在本文中,其他環狀 基團可為雜環烷基,但亦可為不同類型的環狀基團,諸如環烷基、芳基以及雜芳基。所述雜環烷基之碳原子數可為2至60、具體言之2至40且更具體言之3至20。 In the present specification, heterocycloalkyl includes O, S, Se, N or Si as a hetero atom, including monocyclic or polycyclic groups having 2 to 60 carbon atoms, and may be further substituted by other substituents. In this article, polycyclic means a group in which the heterocycloalkyl is directly connected to other cyclic groups or fused with other cyclic groups. In this article, other cyclic groups may be heterocycloalkyl, but may also be different types of cyclic groups, such as cycloalkyl, aryl and heteroaryl. The number of carbon atoms of the heterocycloalkyl may be 2 to 60, specifically 2 to 40 and more specifically 3 to 20.

在本說明書中,芳基包括具有6至60個碳原子的單環或多環,且可進一步經其他取代基取代。在本文中,多環意謂其中芳基直接連接至其他環狀基團或與其他環狀基團稠合的基團。在本文中,其他環狀基團可為芳基,但亦可為不同類型的環狀基團,諸如環烷基、雜環烷基以及雜芳基。芳基包括螺環基團。芳基之碳原子數可為6至60、具體言之6至40且更具體言之6至25。芳基之具體實例可包括苯基、聯苯基、聯三苯基、萘基、蒽基、

Figure 107134589-A0305-02-0010-191
基、菲基、苝基、茀蒽基、聯伸三苯基、丙烯合萘基、芘基、稠四苯基、稠五苯基、茀基、茚基、苊基、苯并茀、螺聯茀基、2,3-二氫-1H-茚基、其稠環以及類似基團,但不限於此。 In the present specification, aryl includes monocyclic or polycyclic rings having 6 to 60 carbon atoms, and may be further substituted by other substituents. In this article, polycyclic means a group in which aryl is directly connected to other cyclic groups or fused with other cyclic groups. In this article, other cyclic groups may be aryl groups, but may also be different types of cyclic groups, such as cycloalkyl, heterocycloalkyl and heteroaryl. Aryl includes spirocyclic groups. The number of carbon atoms of aryl may be 6 to 60, specifically 6 to 40 and more specifically 6 to 25. Specific examples of aryl may include phenyl, biphenyl, terphenyl, naphthyl, anthracenyl,
Figure 107134589-A0305-02-0010-191
The invention also includes, but is not limited to, 1,2-dihydro-1H-indenyl, 2,3-dihydro-1H-indenyl, 2,4 ...

在本說明書中,矽烷基為包括Si、具有直接地連接作為基團之Si原子的取代基,且由-SiR104R105R106表示。R104至R106彼此相同或不同,且可各自獨立地為由以下中之至少一者形成的取代基:氫、氘、鹵基、烷基、烯基、烷氧基、環烷基、芳基以及雜環基。矽烷基的具體實例可包括三甲基矽烷基、三乙基矽烷基、第三丁基二甲基矽烷基、乙烯基二甲基矽烷基、丙基二甲基矽烷基、三苯基矽烷基、二苯基矽烷基、苯基矽烷基以及類似基團,但不限於此。 In the present specification , a silyl group is a substituent including Si, having a Si atom directly connected as a group, and is represented by -SiR104R105R106 . R104 to R106 are the same or different from each other, and may each independently be a substituent formed of at least one of the following: hydrogen, deuterium, halogen, alkyl, alkenyl, alkoxy, cycloalkyl, aryl, and heterocyclic groups. Specific examples of the silyl group may include trimethylsilyl, triethylsilyl, tert-butyldimethylsilyl, vinyldimethylsilyl, propyldimethylsilyl, triphenylsilyl, diphenylsilyl, phenylsilyl, and the like, but are not limited thereto.

在本發明中,茀基可經取代,且相鄰取代基可彼此鍵結形成環。 In the present invention, the fluorene group may be substituted, and adjacent substituents may bond to each other to form a ring.

當茀基經取代時,可包含

Figure 107134589-A0305-02-0011-6
Figure 107134589-A0305-02-0011-7
Figure 107134589-A0305-02-0011-8
Figure 107134589-A0305-02-0011-9
Figure 107134589-A0305-02-0011-10
Figure 107134589-A0305-02-0011-11
以及類似基團。然而,所述結構不限於此。 When the fluorene group is substituted, it may contain
Figure 107134589-A0305-02-0011-6
,
Figure 107134589-A0305-02-0011-7
,
Figure 107134589-A0305-02-0011-8
,
Figure 107134589-A0305-02-0011-9
,
Figure 107134589-A0305-02-0011-10
,
Figure 107134589-A0305-02-0011-11
And similar groups. However, the structure is not limited thereto.

在本說明書中,雜芳基包括O、S、Se、N或Si作為雜原子,包括具有2至60個碳原子的單環或多環,且可進一步經其他取代基取代。在本文中,多環意謂其中雜芳基直接連接至其他環狀基團或與其他環狀基團稠合的基團。在本文中,其他環狀基團可為雜芳基,但亦可為不同類型的環狀基團,諸如環烷基、雜環烷基以及芳基。雜芳基之碳原子數可為2至60,具體言之2至40且更具體言之3至25。雜芳基之具體實例可包括吡啶基、吡咯基、嘧啶基、噠嗪基(pyridazine)、呋喃基、噻吩基、咪唑基、吡唑基、噁唑基、異噁唑基、噻唑基、異噻唑基、三唑基、呋吖基、噁二唑基、噻二唑基、二噻唑基、四唑基、哌喃基、噻喃基、二嗪基、噁嗪基、噻嗪基、二氧基(dioxynyl)、三嗪基、四嗪基、喹啉基(quinolyl group)、異喹啉基、喹唑啉基(quinazolinyl group)、異喹唑啉基、喹嗪啉基(quinozolinyl group)、萘啶基、吖啶基、啡啶基、咪唑并吡啶基、二氮雜萘基(diazanaphthalenyl group)、三氮雜茚基(triazaindene group)、吲哚基、吲哚嗪基(indolizinyl group)、苯并噻唑基、苯并噁唑基、苯并咪唑基、苯并噻吩基、苯并呋喃基、二苯并噻吩基、二苯并呋喃基、咔唑基、苯并咔唑 基、二苯并咔唑基、啡嗪基、二苯并矽呃基(dibenzosilole group)、螺二(二苯并矽呃)基、二氫啡嗪基(dihydrophenazinyl group)、啡噁嗪基、菲啶基(phenanthridyl group)、咪唑并吡啶基、噻吩基(thienyl)、吲哚并[2,3-a]咔唑基、吲哚并[2,3-b]咔唑基、二氫吲哚基、10,11-二氫-二苯并[b,f]吖呯基、9,10-二氫吖啶基、菲蒽吖嗪基(phenanthrazinyl group)、噻吩嗪基(phenothiathiazinyl group)、酞嗪基、萘啶基(naphthylidinyl group)、啡啉基、苯并[c][1,2,5]噻二唑基(benzo[c][1,2,5]thiadiazolyl group)、5,10-二氫苯并[b,e][1,4]氮雜矽啉基(5,10-dihydrobenzo[b,e][1,4]azasilinyl)、吡唑并[1,5-c]喹唑啉基(pyrazolo[1,5-c]quinazolinyl group)、吡啶并[1,2-b]吲唑基(pyrido[1,2-b]indazolyl group)、吡啶并[1,2-a]咪唑并[1,2-e]二氫吲哚基(pyrido[1,2-a]imidazo[1,2-e]indolinyl group)、5,11-二氫茚并[1,2-b]咔唑基(5,11-dihydroindeno[1,2-b]carbazolyl group)以及類似基團,但不限於此。 In the present specification, heteroaryl includes O, S, Se, N or Si as heteroatoms, including monocyclic or polycyclic rings with 2 to 60 carbon atoms, and may be further substituted by other substituents. In this article, polycyclic means a group in which the heteroaryl is directly connected to other cyclic groups or fused to other cyclic groups. In this article, other cyclic groups can be heteroaryl, but can also be different types of cyclic groups, such as cycloalkyl, heterocycloalkyl and aryl. The number of carbon atoms of the heteroaryl can be 2 to 60, specifically 2 to 40 and more specifically 3 to 25. Specific examples of the heteroaryl group may include pyridyl, pyrrolyl, pyrimidinyl, pyridazine, furanyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, furazolyl, oxadiazolyl, thiadiazolyl, dithiazolyl, tetrazolyl, pyranyl, thiopyranyl, diazinyl, oxazinyl, thiazinyl, dioxynyl, triazinyl, tetrazinyl, quinolyl group, isoquinolyl, quinazolinyl group, isoquinazolinyl, quinozolinyl group, naphthyridinyl, acridinyl, phenanthidinyl, imidazopyridinyl, diazanaphthalenyl group, triazaindene group, group), indolyl, indolizinyl group, benzothiazolyl, benzoxazolyl, benzimidazolyl, benzothiophenyl, benzofuranyl, dibenzothiophenyl, dibenzofuranyl, carbazolyl, benzocarbazolyl, dibenzocarbazolyl, phenazinyl, dibenzosilole group, spirobi(dibenzosilole) group, dihydrophenazinyl group, phenoxazinyl, phenanthridyl group), imidazopyridyl, thienyl, indolo[2,3-a]carbazolyl, indolo[2,3-b]carbazolyl, dihydroindolyl, 10,11-dihydro-dibenzo[b,f]aziryl, 9,10-dihydroaziridine, phenanthrazinyl group, phenothiathiazinyl group, phthalazinyl, naphthyldinyl group, phenanthrydinyl, benzo[c][1,2,5]thiadiazolyl group), 5,10-dihydrobenzo[b,e][1,4]azasilinyl, pyrazolo[1,5-c]quinazolinyl, pyrido[1,2-b]indazolyl, pyrido[1,2-a]imidazo[1,2-e]indolinyl, 5,11-dihydroindeno[1,2-b]carbazolyl, and similar groups, but not limited thereto.

在本說明書中,胺基可能是由下列各者所構成的族群中選出:單烷基胺基、單芳基胺基、單雜芳基胺基、-NH2、二烷基胺基、二芳基胺基、二雜芳基胺基、烷基芳基胺基、烷基雜芳基胺基以及芳基雜芳基胺基,且儘管碳原子數不受其特定限制,但較佳為1至30。所述胺基之具體實例可包括甲胺基、二甲胺基、乙胺基、二乙胺基、苯胺基、萘胺基、聯苯胺基、二聯苯胺基、蒽胺基、9-甲基-蒽胺基、二苯胺基、苯基萘胺基、二甲苯胺基、苯基甲苯胺基、三苯胺基、聯苯萘胺基、苯基聯苯胺基、聯苯茀胺基、苯基伸三苯基胺基、聯苯基伸三苯基胺基以及類似基團, 但不限於此。 In the present specification, the amine group may be selected from the group consisting of monoalkylamine, monoarylamine, monoheteroarylamine, -NH2 , dialkylamine, diarylamine, diheteroarylamine, alkylarylamine, alkylheteroarylamine and arylheteroarylamine, and although the number of carbon atoms is not particularly limited, it is preferably 1 to 30. Specific examples of the amino group may include methylamino, dimethylamino, ethylamino, diethylamino, aniline, naphthylamino, benzidine, dibenzidine, anthracenyl, 9-methyl-anthridine, diphenylamine, phenylnaphthylamine, dimethylamino, phenyltoluidine, triphenylamine, diphenylnaphthylamine, phenylbenzidine, diphenylfluorenylamine, phenyltriphenylamine, diphenyltriphenylamine and the like, but are not limited thereto.

在本說明書中,伸芳基意謂具有兩個鍵結位點的芳基,亦即二價基團。除各自為二價基團以外,以上所提供之關於芳基的描述可應用於此。此外,伸雜芳基意謂具有兩個鍵結位點之雜芳基,亦即二價基團。除各自為二價基團以外,以上所提供之關於雜芳基的描述可應用於此。 In this specification, an aryl group means an aryl group having two bonding sites, i.e., a divalent group. Except for each being a divalent group, the description of the aryl group provided above can be applied here. In addition, a heteroaryl group means a heteroaryl group having two bonding sites, i.e., a divalent group. Except for each being a divalent group, the description of the heteroaryl group provided above can be applied here.

在本說明書中,氧化膦基團之具體實例可包含氧化二苯膦基、氧化二萘基膦基以及類似基團,但不限於此。 In this specification, specific examples of phosphine oxide groups may include diphenylphosphine oxide, dinaphthylphosphine oxide, and similar groups, but are not limited thereto.

在本說明書中,「相鄰」基團可意謂取代與對應取代基所取代的原子直接鍵聯的原子的取代基、空間位置最接近對應取代基的取代基,或取代對應取代基所取代的原子的另一取代基。舉例而言,取代苯環中之鄰位之兩個取代基及取代脂族環中之同一碳之兩個取代基可解釋為彼此「相鄰」之基團。 In this specification, "adjacent" groups may mean a substituent that replaces an atom directly bonded to the atom replaced by the corresponding substituent, a substituent that is closest in space to the corresponding substituent, or another substituent that replaces the atom replaced by the corresponding substituent. For example, two substituents that replace adjacent positions in a benzene ring and two substituents that replace the same carbon in an aliphatic ring can be interpreted as "adjacent" groups to each other.

在本說明書中,術語「取代」意謂鍵結至化合物之碳原子的氫原子變成另一取代基,且取代之位置不受限制,只要所述位置為氫原子經取代之位置,亦即取代基可取代之位置,且在兩個或更多個取代基取代時,所述兩個或更多個取代基可彼此相同或不同。 In this specification, the term "substituted" means that the hydrogen atom bonded to the carbon atom of the compound is changed into another substituent, and the position of substitution is not limited, as long as the position is the position where the hydrogen atom is substituted, that is, the position where the substituent can be substituted, and when two or more substituents are substituted, the two or more substituents can be the same or different from each other.

在本說明書中,「經取代或未經取代」意謂經由下列各者所構成的族群中選出的一或多個取代基取代:C1至C60直鏈或分支鏈烷基、C2至C60直鏈或分支鏈烯基、C2至C60直鏈或分支鏈炔基、C3至C60單環或多環環烷基、C2至C60單環或多環雜環烷基、C6至C60單環或多環芳基、C2至C60單環或多環雜芳基、-SiRR'R"、-P(=O)RR'、C1至C20烷胺、C6至C60單環或多 環芳基胺及C2至C60單環或多環雜芳基胺,或未經取代,或經連接由以上示出之取代基中選出之兩個或更多個取代基的取代基取代,或未經取代。 In the present specification, "substituted or unsubstituted" means substituted by one or more substituents selected from the group consisting of: C1 to C60 straight or branched chain alkyl, C2 to C60 straight or branched chain alkenyl, C2 to C60 straight or branched chain alkynyl, C3 to C60 monocyclic or polycyclic cycloalkyl, C2 to C60 monocyclic or polycyclic heterocyclic alkyl, C6 to C60 monocyclic or polycyclic heterocyclic alkyl, Cyclic or polycyclic aromatic group, C2 to C60 monocyclic or polycyclic heteroaromatic group, -SiRR'R", -P(=O)RR', C1 to C20 alkylamine, C6 to C60 monocyclic or polycyclic aromatic amine and C2 to C60 monocyclic or polycyclic heteroaromatic amine, or unsubstituted, or substituted by a substituent connected by two or more substituents selected from the substituents shown above, or unsubstituted.

本申請案的一個實施例提供由化學式1表示的化合物。 An embodiment of the present application provides a compound represented by Chemical Formula 1.

化學式1具有喹啉基稠合至吲哚基之結構,且當具有吲哚基時,化學式1具有在該結構中之sp3未共用電子對而非sp2未共用電子對。因此,相比有具有sp2非共價鍵之苯并噻吩或苯并呋喃時,電洞轉移特性尤其優良。此影響在後來用作有機發光裝置之有機材料層時的發光層中之激子形成,從而引起裝置效率及壽命的增加。 Chemical formula 1 has a structure in which a quinoline group is fused to an indole group, and when having an indole group, Chemical formula 1 has an sp3 unshared electron pair in the structure instead of an sp2 unshared electron pair. Therefore, compared with benzothiophene or benzofuran having an sp2 non-covalent bond, the hole transfer property is particularly excellent. This affects the formation of excitons in the light-emitting layer when it is later used as an organic material layer of an organic light-emitting device, thereby causing an increase in device efficiency and life.

在本申請案之一個實施例中,化學式1之R2至R5彼此相同或不同,且可各自獨立地是由下列各者所構成的族群中選出:氫、氘、鹵基、-CN、經取代或未經取代之烷基、經取代或未經取代之烯基、經取代或未經取代之炔基、經取代或未經取代之烷氧基、經取代或未經取代之環烷基、經取代或未經取代之雜環烷基、經取代或未經取代之芳基、經取代或未經取代之雜芳基、SiRR'R"、-P(=O)RR'以及胺基,所述胺基未經取代或經以下取代:經取代或未經取代之烷基、經取代或未經取代之芳基或經取代或未經取代之雜芳基,或彼此相鄰的兩個或更多個基團可彼此鍵結以形成經取代或未經取代之脂族或芳族烴環。 In one embodiment of the present application, R 2 to R 5 are the same as or different from each other and may be each independently selected from the group consisting of hydrogen, deuterium, halogen, -CN, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, SiRR'R", -P(=O)RR' and amine, wherein the amine is unsubstituted or substituted with substituted or unsubstituted alkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, or two or more groups adjacent to each other may be bonded to each other to form a substituted or unsubstituted aliphatic or aromatic hydrocarbon ring.

在另一實施例中,化學式1之R2至R5彼此相同或不同,且可各自獨立地是由下列各者所構成的族群中選出:氫、經取代或未經取代之C1至C60芳基,及經取代或未經取代之C2至C60雜芳基,或彼此相鄰的兩個或更多個基團可彼此鍵結以形成經取 代或未經取代之芳族烴環。 In another embodiment, R2 to R5 of Chemical Formula 1 are the same as or different from each other, and may be independently selected from the group consisting of hydrogen, a substituted or unsubstituted C1 to C60 aryl group, and a substituted or unsubstituted C2 to C60 heteroaryl group, or two or more adjacent groups may be bonded to each other to form a substituted or unsubstituted aromatic hydrocarbon ring.

在另一實施例中,化學式1之R2至R5彼此相同或不同,且可各獨立地為氫,或彼此相鄰的兩個或更多個基團可彼此鍵結而形成經取代或未經取代之C6至C60芳族烴環。 In another embodiment, R2 to R5 of Chemical Formula 1 are the same as or different from each other and may each independently be hydrogen, or two or more adjacent groups may be bonded to each other to form a substituted or unsubstituted C6 to C60 aromatic hydrocarbon ring.

在另一實施例中,化學式1之R2至R5彼此相同或不同,且可各獨立地為氫,或彼此相鄰的兩個或更多個基團可彼此鍵結而形成C6至C40芳族烴環。 In another embodiment, R2 to R5 of Chemical Formula 1 are the same as or different from each other and may each independently be hydrogen, or two or more adjacent groups may be bonded to each other to form a C6 to C40 aromatic hydrocarbon ring.

在另一實施例中,化學式1之R2至R5彼此相同或不同,且可各獨立地為氫,或彼此相鄰的兩個或更多個基團可彼此鍵結而形成苯環。 In another embodiment, R2 to R5 in Chemical Formula 1 are the same as or different from each other and may each independently be hydrogen, or two or more adjacent groups may be bonded to each other to form a benzene ring.

在本申請案的一個實施例中,化學式1之R2至R5當中的R2及R3彼此鍵結而形成苯環,且其餘可為氫。 In one embodiment of the present application, R 2 and R 3 among R 2 to R 5 in Chemical Formula 1 are bonded to each other to form a benzene ring, and the remainder may be hydrogen.

在本申請案的一個實施例中,化學式1之R2至R5當中的R3及R4彼此鍵結而形成苯環,且其餘可為氫。 In one embodiment of the present application, R 3 and R 4 among R 2 to R 5 in Chemical Formula 1 are bonded to each other to form a benzene ring, and the rest may be hydrogen.

在本申請案的一個實施例中,化學式1之R2至R5當中的R4及R5彼此鍵結而形成苯環,且其餘可為氫。 In one embodiment of the present application, R 4 and R 5 among R 2 to R 5 in Chemical Formula 1 are bonded to each other to form a benzene ring, and the rest may be hydrogen.

在本申請案的一個實施例中,化學式1之Ra可為氫、經取代或未經取代之烷基、經取代或未經取代之芳基,或經取代或未經取代之雜芳基。 In one embodiment of the present application, Ra of Chemical Formula 1 may be hydrogen, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group.

在另一實施例中,化學式1之Ra可為氫、經取代或未經取代的C6至C60芳基,或經取代或未經取代的C2至C60雜芳基。 In another embodiment, Ra of Chemical Formula 1 may be hydrogen, a substituted or unsubstituted C6 to C60 aryl group, or a substituted or unsubstituted C2 to C60 heteroaryl group.

在另一實施例中,化學式1之Ra可為氫、C6至C40芳基,或C2至C40雜芳基。 In another embodiment, Ra of Chemical Formula 1 may be hydrogen, C6 to C40 aryl, or C2 to C40 heteroaryl.

在另一實施例中,化學式1之Ra可為氫。 In another embodiment, Ra of Chemical Formula 1 may be hydrogen.

在本申請案的一個實施例中,Ar1可由-(L1)p-(Z1)q表示,且Ar2可由-(L2)r-(Z2)s表示。 In one embodiment of the present application, Ar 1 may be represented by -(L1)p-(Z1)q, and Ar 2 may be represented by -(L2)r-(Z2)s.

因本申請案之化學式1之Ar1及Ar2經各取代基取代,與在經單取代時相比,熱穩定性優良,且與在經單取代時相比,可以更多樣方式引入控制電洞轉移特性的在結構上經吲哚構造的取代基,且控制結構特性可優良。 Since Ar 1 and Ar 2 in Chemical Formula 1 of the present application are substituted with various substituents, the thermal stability is better than when they are substituted with a single group, and compared with when they are substituted with a single group, substituents with an indole structure that control the hole transfer characteristics can be introduced in a more diverse manner, and the structural characteristics can be controlled better.

在本申請案的一個實施例中,L1及L2彼此相同或不同,且可各獨立地為經取代或未經取代之伸芳基,或經取代或未經取代之伸雜芳基。 In one embodiment of the present application, L1 and L2 are the same or different from each other, and can be independently a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group.

在另一實施例中,L1及L2彼此相同或不同,且可各獨立地為經取代或未經取代之C6至C60伸芳基,或經取代或未經取代之C2至C60伸雜芳基。 In another embodiment, L1 and L2 are the same or different from each other, and can each independently be a substituted or unsubstituted C6 to C60 aryl group, or a substituted or unsubstituted C2 to C60 heteroaryl group.

在另一實施例中,L1及L2彼此相同或不同,且可各獨立地為C6至C40伸芳基,或C2至C40伸雜芳基。 In another embodiment, L1 and L2 are the same or different from each other, and can each independently be a C6 to C40 aryl group, or a C2 to C40 heteroaryl group.

在另一實施例中,L1及L2彼此相同或不同,且可各獨立地為C6至C40伸芳基,或C2至C40伸雜芳基。 In another embodiment, L1 and L2 are the same or different from each other, and can each independently be a C6 to C40 aryl group, or a C2 to C40 heteroaryl group.

在另一實施例中,L1及L2彼此相同或不同,且可各獨立地為伸苯基、伸聯苯基、萘基、伸菲基、伸聯伸三苯基、伸茀蒽基、伸芘基、二價吡啶基、二價嘧啶基,或二價三嗪基。 In another embodiment, L1 and L2 are the same or different from each other, and can be independently a phenyl group, a biphenyl group, a naphthyl group, a phenanthryl group, a triphenyl group, a fluorenthranyl group, a pyrene group, a divalent pyridyl group, a divalent pyrimidyl group, or a divalent triazine group.

在本申請案之一個實施例中,L1可為經取代或未經取代之C6至C60伸芳基,或經取代或未經取代之C2至C60伸雜芳基。 In one embodiment of the present application, L1 may be a substituted or unsubstituted C6 to C60 aryl group, or a substituted or unsubstituted C2 to C60 heteroaryl group.

在另一實施例中,L1可為經取代或未經取代的C6至C40伸芳基,或經取代或未經取代的C2至C40伸雜芳基。 In another embodiment, L1 may be a substituted or unsubstituted C6 to C40 aryl group, or a substituted or unsubstituted C2 to C40 heteroaryl group.

在另一實施例中,L1可為C6至C40伸芳基,或C2至 C40伸雜芳基。 In another embodiment, L1 may be a C6 to C40 aryl group, or a C2 to C40 heteroaryl group.

在另一實施例中,L1可為伸苯基、伸聯苯基、萘基、伸菲基、二價吡啶基、二價嘧啶基或二價三嗪基。 In another embodiment, L1 can be a phenyl group, a biphenyl group, a naphthyl group, a phenanthryl group, a divalent pyridyl group, a divalent pyrimidyl group, or a divalent triazine group.

在本申請案之一個實施例中,L2可為經取代或未經取代之C6至C60伸芳基,或經取代或未經取代之C2至C60伸雜芳基。 In one embodiment of the present application, L2 may be a substituted or unsubstituted C6 to C60 aryl group, or a substituted or unsubstituted C2 to C60 heteroaryl group.

在另一實施例中,L2可為經取代或未經取代的C6至C40伸芳基,或經取代或未經取代的C2至C40伸雜芳基。 In another embodiment, L2 may be a substituted or unsubstituted C6 to C40 aryl group, or a substituted or unsubstituted C2 to C40 heteroaryl group.

在另一實施例中,L2可為C6至C40伸芳基,或C2至C40伸雜芳基。 In another embodiment, L2 may be a C6 to C40 aryl group, or a C2 to C40 heteroaryl group.

在另一實施例中,L2可為伸苯基、伸聯苯基、萘基、伸菲基、伸聯伸三苯基、伸茀蒽基、伸芘基、二價吡啶基、二價嘧啶基或二價三嗪基。 In another embodiment, L2 can be a phenyl group, a biphenyl group, a naphthyl group, a phenanthryl group, a triphenyl group, a fluorenanthryl group, a pyrene group, a divalent pyridyl group, a divalent pyrimidyl group, or a divalent triazine group.

在本申請案的一個實施例中,Z1及Z2彼此相同或不同,且可各獨立地是由下列各者所構成的族群中選出:氫;氘;鹵基;-CN;經取代或未經取代之烷基;經取代或未經取代之烯基;經取代或未經取代之炔基;經取代或未經取代之烷氧基;經取代或未經取代之環烷基;經取代或未經取代之雜環烷基;經取代或未經取代之芳基;經取代或未經取代之雜芳基;-SiRR'R";-P(=O)RR';及胺基,所述胺基未經取代或經以下取代:經取代或未經取代之烷基、經取代或未經取代之芳基或經取代或未經取代之雜芳基。 In one embodiment of the present application, Z1 and Z2 are the same or different from each other, and can be independently selected from the group consisting of: hydrogen; deuterium; halogen; -CN; substituted or unsubstituted alkyl; substituted or unsubstituted alkenyl; substituted or unsubstituted alkynyl; substituted or unsubstituted alkoxy; substituted or unsubstituted cycloalkyl; substituted or unsubstituted heterocycloalkyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; -SiRR'R"; -P(=O)RR'; and amino, which is unsubstituted or substituted with: substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

在另一實施例中,Z1及Z2彼此相同或不同,且可各獨立地為氫、經取代或未經取代之芳基、經取代或未經取代之雜芳基或P(=O)RR'。 In another embodiment, Z1 and Z2 are the same or different from each other, and can each independently be hydrogen, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, or P(=O)RR'.

在另一實施例中,Z1及Z2彼此相同或不同,且可各獨 立地為氫、經取代或未經取代之C6至C60芳基、經取代或未經取代之C2至C60雜芳基或P(=O)RR'。 In another embodiment, Z1 and Z2 are the same or different from each other and can be independently hydrogen, a substituted or unsubstituted C6 to C60 aryl group, a substituted or unsubstituted C2 to C60 heteroaryl group or P(=O)RR'.

在另一實施例中,Z1及Z2彼此相同或不同,且可各獨立地為氫、經取代或未經取代之C6至C40芳基、經取代或未經取代之C2至C40雜芳基或P(=O)RR'。 In another embodiment, Z1 and Z2 are the same or different from each other, and can each independently be hydrogen, a substituted or unsubstituted C6 to C40 aryl group, a substituted or unsubstituted C2 to C40 heteroaryl group, or P(=O)RR'.

在另一實施例中,Z1及Z2彼此相同或不同,且可各獨立地為氫;C6至C40芳基,其未經取代或經由下列各者所構成的族群中選出的一或多個取代基取代:C6至C40芳基、C2至C40雜芳基、C1至C40烷基及-CN;C2至C40雜芳基,其未經取代或經C6至C40芳基取代;或P(=O)RR',且所述取代基可未經取代或再次經C1至C40烷基或C6至C40芳基取代。 In another embodiment, Z1 and Z2 are the same or different from each other and may be independently hydrogen; C6 to C40 aryl, which is unsubstituted or substituted by one or more substituents selected from the group consisting of: C6 to C40 aryl, C2 to C40 heteroaryl, C1 to C40 alkyl and -CN; C2 to C40 heteroaryl, which is unsubstituted or substituted by C6 to C40 aryl; or P(=O)RR', and the substituent may be unsubstituted or substituted again by C1 to C40 alkyl or C6 to C40 aryl.

在另一實施例中,Z1及Z2彼此相同或不同,且可各獨立地為氫;P(=O)RR';苯基,其未經取代或經由下列各者所構成的族群中選出的一或多個取代基取代:9,9'-二甲基茀基、-CN、聯伸三苯基、菲基、苯基、二苯并呋喃基及二苯并噻吩基;苯基,其未經取代或經咔唑基取代,所述咔唑基未經取代或經苯基取代;聯苯基;聯伸三苯基;茀基,其未經取代或經甲基取代;菲基;螺茀基;吡啶基;咔唑基;二苯并呋喃基;二苯并噻吩基;或啡啉基,其未經取代或經苯基取代。 In another embodiment, Z1 and Z2 are the same or different from each other and can be independently hydrogen; P(=O)RR'; phenyl, which is unsubstituted or substituted by one or more substituents selected from the group consisting of: 9,9'-dimethylfluorenyl, -CN, triphenylene, phenanthrenyl, phenyl, dibenzofuranyl and dibenzothienyl; phenyl, which is unsubstituted or substituted by carbazolyl, which is unsubstituted or substituted by phenyl; biphenyl; triphenylene; fluorenyl, which is unsubstituted or substituted by methyl; phenanthrenyl; spirofluorenyl; pyridyl; carbazolyl; dibenzofuranyl; dibenzothienyl; or phenanthroline, which is unsubstituted or substituted by phenyl.

在本申請案的一個實施例中,Z1可為氫;P(=O)RR';苯基,其未經取代或經由下列各者所構成的族群中選出的一或多個取代基取代:咔唑基,其未經取代或經苯基、二苯并呋喃基及二苯并噻吩基取代;聯苯基、螺二茀基;茀基,其未經取代或經甲基取代;吡啶基;二苯并呋喃基;二苯并噻吩基;或啡啉基 (phenanthroline group),其未經取代或經苯基取代。 In one embodiment of the present application, Z1 may be hydrogen; P(=O)RR'; phenyl, which is unsubstituted or substituted by one or more substituents selected from the group consisting of: carbazolyl, which is unsubstituted or substituted by phenyl, dibenzofuranyl and dibenzothienyl; biphenyl, spirobifluorenyl; fluorenyl, which is unsubstituted or substituted by methyl; pyridyl; dibenzofuranyl; dibenzothienyl; or phenanthroline group, which is unsubstituted or substituted by phenyl.

在本申請案的一個實施例中,Z2可為氫;P(=O)RR';苯基,其未經取代或經由下列各者所構成的族群中選出的一或多個取代基取代:苯基、菲基、聯伸三苯基、-CN、9,9'-二甲基茀基、咔唑基及二苯并呋喃基;聯苯基;聯伸三苯基;茀基,其未經取代或經甲基取代;菲基;吡啶基;咔唑基;或二苯并呋喃基。 In one embodiment of the present application, Z2 may be hydrogen; P(=O)RR'; phenyl, which is unsubstituted or substituted by one or more substituents selected from the group consisting of: phenyl, phenanthrenyl, triphenylene, -CN, 9,9'-dimethylfluorenyl, carbazolyl and dibenzofuranyl; biphenyl; triphenylene; fluorenyl, which is unsubstituted or substituted by methyl; phenanthrenyl; pyridyl; carbazolyl; or dibenzofuranyl.

在本申請案的一個實施例中,R、R'及R"彼此相同或不同,且可各自獨立地為氫;氘;-CN;經取代或未經取代的烷基;經取代或未經取代的環烷基;經取代或未經取代的芳基;或經取代或未經取代的雜芳基。 In one embodiment of the present application, R, R' and R" are the same or different from each other, and can be independently hydrogen; deuterium; -CN; substituted or unsubstituted alkyl; substituted or unsubstituted cycloalkyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl.

在另一實施例中,R、R'及R"彼此相同或不同,且可各自獨立地為經取代或未經取代的芳基。 In another embodiment, R, R' and R" are the same or different from each other, and can each independently be a substituted or unsubstituted aryl group.

在另一實施例中,R、R'及R"彼此相同或不同,且可各自獨立地為經取代或未經取代的C6至C60芳基。 In another embodiment, R, R' and R" are the same or different from each other, and can each independently be a substituted or unsubstituted C6 to C60 aryl group.

在另一實施例中,R、R'及R"彼此相同或不同,且可各自獨立地為經取代或未經取代的C6至C40芳基。 In another embodiment, R, R' and R" are the same or different from each other, and can each independently be a substituted or unsubstituted C6 to C40 aryl group.

在另一實施例中,R、R'及R"彼此相同或不同,且可各自獨立地為C6至C40芳基。 In another embodiment, R, R' and R" are the same or different from each other, and can each independently be a C6 to C40 aryl group.

在另一實施例中,R、R'及R"彼此相同或不同,且可各自獨立地為苯基。 In another embodiment, R, R' and R" are the same or different from each other and can each independently be a phenyl group.

在本申請案之一個實施例中提供的雜環化合物中,化學式1可由以下化學式2至化學式9中之任一者表示。 In the heterocyclic compound provided in one embodiment of the present application, Chemical Formula 1 can be represented by any one of the following Chemical Formulas 2 to 9.

[化學式2]

Figure 107134589-A0305-02-0020-12
[Chemical formula 2]
Figure 107134589-A0305-02-0020-12

Figure 107134589-A0305-02-0020-13
Figure 107134589-A0305-02-0020-13

Figure 107134589-A0305-02-0020-14
Figure 107134589-A0305-02-0020-14

[化學式5]

Figure 107134589-A0305-02-0021-15
[Chemical formula 5]
Figure 107134589-A0305-02-0021-15

Figure 107134589-A0305-02-0021-16
Figure 107134589-A0305-02-0021-16

Figure 107134589-A0305-02-0021-17
Figure 107134589-A0305-02-0021-17

[化學式8]

Figure 107134589-A0305-02-0022-18
[Chemical formula 8]
Figure 107134589-A0305-02-0022-18

Figure 107134589-A0305-02-0022-19
Figure 107134589-A0305-02-0022-19

在化學式2至化學式9中,Ra、Ar1、Ar2、R2至R5及n之定義與化學式1中相同。 In Chemical Formulae 2 to 9, Ra, Ar 1 , Ar 2 , R 2 to R 5 and n have the same meanings as in Chemical Formula 1.

在本申請案的一個實施例中提供的雜環化合物中,化學式1由以下化合物中的任一者表示。 In the heterocyclic compound provided in one embodiment of the present application, Chemical Formula 1 is represented by any one of the following compounds.

Figure 107134589-A0305-02-0023-20
Figure 107134589-A0305-02-0023-20

Figure 107134589-A0305-02-0024-21
Figure 107134589-A0305-02-0024-21

Figure 107134589-A0305-02-0025-22
Figure 107134589-A0305-02-0025-22

Figure 107134589-A0305-02-0026-26
Figure 107134589-A0305-02-0026-26

Figure 107134589-A0305-02-0027-27
Figure 107134589-A0305-02-0027-27

Figure 107134589-A0305-02-0028-28
Figure 107134589-A0305-02-0028-28

Figure 107134589-A0305-02-0029-29
Figure 107134589-A0305-02-0029-29

Figure 107134589-A0305-02-0030-30
Figure 107134589-A0305-02-0030-30

Figure 107134589-A0305-02-0031-31
Figure 107134589-A0305-02-0031-31

Figure 107134589-A0305-02-0032-32
Figure 107134589-A0305-02-0032-32

Figure 107134589-A0305-02-0033-33
Figure 107134589-A0305-02-0033-33

Figure 107134589-A0305-02-0034-34
Figure 107134589-A0305-02-0034-34

Figure 107134589-A0305-02-0035-35
Figure 107134589-A0305-02-0035-35

Figure 107134589-A0305-02-0036-36
Figure 107134589-A0305-02-0036-36

Figure 107134589-A0305-02-0037-37
Figure 107134589-A0305-02-0037-37

Figure 107134589-A0305-02-0038-39
Figure 107134589-A0305-02-0038-39

Figure 107134589-A0305-02-0039-40
Figure 107134589-A0305-02-0039-40

Figure 107134589-A0305-02-0040-41
Figure 107134589-A0305-02-0040-41

Figure 107134589-A0305-02-0041-42
Figure 107134589-A0305-02-0041-42

Figure 107134589-A0305-02-0042-44
Figure 107134589-A0305-02-0042-44

Figure 107134589-A0305-02-0043-45
Figure 107134589-A0305-02-0043-45

根據本發明之一個實施例之化合物可根據以下通式1製備。 The compound according to one embodiment of the present invention can be prepared according to the following general formula 1.

Figure 107134589-A0305-02-0044-46
Figure 107134589-A0305-02-0044-46

在通式1中,R10或R11之定義與化學式1之Ar1或Ar2相同。 In Formula 1, R 10 or R 11 has the same definition as Ar 1 or Ar 2 in Formula 1.

此外,藉由將各種取代基引入至化學式1至化學式9之結構,可合成具有所引入取代基之獨特特性的化合物。舉例而言,藉由將取代基(通常用作用於製造有機發光裝置之電洞注入層材料、電洞轉移層材料、發光層材料、電子轉移層材料以及電荷產生層材料)引入至核心結構,可合成符合各有機材料層所需條件的材料。 In addition, by introducing various substituents into the structures of Chemical Formulae 1 to 9, compounds having unique characteristics of the introduced substituents can be synthesized. For example, by introducing substituents (usually used as hole injection layer materials, hole transfer layer materials, light-emitting layer materials, electron transfer layer materials, and charge generation layer materials for manufacturing organic light-emitting devices) into the core structure, materials that meet the required conditions of each organic material layer can be synthesized.

此外,藉由將各種取代基引入至化學式1至化學式9之結構,可精細控制能帶隙,且同時,強化在有機材料之間的界面處之特性,且材料應用可變得多樣化。 Furthermore, by introducing various substituents into the structures of Chemical Formula 1 to Chemical Formula 9, the energy band gap can be finely controlled, and at the same time, the characteristics at the interface between organic materials can be enhanced, and the material applications can be diversified.

同時,化合物具有高玻璃轉化溫度(Tg),且具有極佳熱穩定性。熱穩定性之這類提高成為向裝置提供驅動穩定性的重要因素。 At the same time, the compound has a high glass transition temperature (Tg) and has excellent thermal stability. Such improvement in thermal stability becomes an important factor in providing driving stability to the device.

根據本申請案的一個實施例的雜環化合物可經由多步化學反應製備。首先製備一些中間化合物,且化學式1之化合物可由所述中間化合物製備。更具體言之,根據本申請案的一個實施例的雜環化合物可基於稍後描述的製備實例來製備。 The heterocyclic compound according to one embodiment of the present application can be prepared through a multi-step chemical reaction. First, some intermediate compounds are prepared, and the compound of Chemical Formula 1 can be prepared from the intermediate compounds. More specifically, the heterocyclic compound according to one embodiment of the present application can be prepared based on the preparation example described later.

本申請案的另一實施例提供有機發光裝置,所述有機發光裝置包括:第一電極;第二電極,其設置為與第一電極相對;以及一或多個有機材料層,其設置於第一電極與第二電極之間,其中有機材料層的一或多個層包括根據化學式1的雜環化合物。 Another embodiment of the present application provides an organic light-emitting device, the organic light-emitting device comprising: a first electrode; a second electrode disposed opposite to the first electrode; and one or more organic material layers disposed between the first electrode and the second electrode, wherein one or more layers of the organic material layer include a heterocyclic compound according to Chemical Formula 1.

在本說明書的一個實施例,第一電極可為陽極,且第二電極可為陰極。 In one embodiment of the present specification, the first electrode may be an anode, and the second electrode may be a cathode.

在另一實施例中,第一電極可為陰極,且第二電極可為陽極。 In another embodiment, the first electrode may be a cathode and the second electrode may be an anode.

在本申請案的一個實施例中,有機發光裝置可為藍色有機發光裝置,且根據化學式1的雜環化合物可用作藍色有機發光裝置的材料。 In one embodiment of the present application, the organic light-emitting device may be a blue organic light-emitting device, and the heterocyclic compound according to Chemical Formula 1 may be used as a material for the blue organic light-emitting device.

在本申請案的一個實施例中,有機發光裝置可為綠色有機發光裝置,且根據化學式1的雜環化合物可用作綠色有機發光裝置的材料。 In one embodiment of the present application, the organic light-emitting device may be a green organic light-emitting device, and the heterocyclic compound according to Chemical Formula 1 may be used as a material for the green organic light-emitting device.

在本申請案的一個實施例中,有機發光裝置可為紅色有機發光裝置,且根據化學式1的雜環化合物可用作紅色有機發光裝置的材料。 In one embodiment of the present application, the organic light-emitting device may be a red organic light-emitting device, and the heterocyclic compound according to Chemical Formula 1 may be used as a material for the red organic light-emitting device.

關於由化學式1表示的雜環化合物的特定描述與以上提供的描述相同。 The specific description about the heterocyclic compound represented by Chemical Formula 1 is the same as the description provided above.

除使用上文所描述的雜環化合物形成一或多個有機材料層以外,本發明的有機發光裝置可使用常用有機發光裝置製造方法及材料來製造。 In addition to using the heterocyclic compound described above to form one or more organic material layers, the organic light-emitting device of the present invention can be manufactured using commonly used organic light-emitting device manufacturing methods and materials.

當製造有機發光裝置時,雜環化合物可經由溶液塗佈方法以及真空沉積法形成為有機材料層。在本文中,溶液塗佈法意 謂旋塗、浸塗、噴墨印刷、網板印刷、噴霧法、滾塗以及類似方法,但不限於此。 When manufacturing an organic light-emitting device, the heterocyclic compound can be formed into an organic material layer via a solution coating method and a vacuum deposition method. In this article, the solution coating method means spin coating, dip coating, inkjet printing, screen printing, spraying, roll coating and the like, but is not limited thereto.

本發明的有機發光裝置的有機材料層可形成於單層結構中,或亦可形成於其中兩個或更多個有機材料層經層壓的多層結構中。舉例而言,根據本發明的一個實施例的有機發光裝置可具有包括以下的結構作為有機材料層:電洞注入層、電洞轉移層、發光層、電子轉移層、電子注入層以及類似者。然而,有機發光裝置的結構不限於此,且可包括較少數目的有機材料層。 The organic material layer of the organic light-emitting device of the present invention may be formed in a single-layer structure, or may also be formed in a multi-layer structure in which two or more organic material layers are laminated. For example, an organic light-emitting device according to an embodiment of the present invention may have a structure including the following as an organic material layer: a hole injection layer, a hole transfer layer, a light-emitting layer, an electron transfer layer, an electron injection layer, and the like. However, the structure of the organic light-emitting device is not limited thereto, and may include a smaller number of organic material layers.

在本發明的有機發光裝置中,有機材料層包括電子注入層或電子轉移層,且電子注入層或電子轉移層可包括雜環化合物。 In the organic light-emitting device of the present invention, the organic material layer includes an electron injection layer or an electron transfer layer, and the electron injection layer or the electron transfer layer may include a heterocyclic compound.

在本發明的有機發光裝置中,有機材料層包括電子轉移層,且電子轉移層可包括雜環化合物。 In the organic light-emitting device of the present invention, the organic material layer includes an electron transfer layer, and the electron transfer layer may include a heterocyclic compound.

在另一有機發光裝置中,有機材料層包括電子阻擋層或電洞阻擋層,且電子阻擋層或電洞阻擋層可包括雜環化合物。 In another organic light-emitting device, the organic material layer includes an electron blocking layer or a hole blocking layer, and the electron blocking layer or the hole blocking layer may include a heterocyclic compound.

在另一有機發光裝置中,有機材料層包括電洞阻擋層,且電洞阻擋層可包括雜環化合物。 In another organic light-emitting device, the organic material layer includes a hole blocking layer, and the hole blocking layer may include a heterocyclic compound.

在另一種有機發光裝置中,有機材料層包括電子轉移層、發光層或電洞阻擋層,且電子轉移層、發光層或電洞阻擋層可包括雜環化合物。 In another organic light-emitting device, the organic material layer includes an electron transfer layer, a light-emitting layer or a hole blocking layer, and the electron transfer layer, the light-emitting layer or the hole blocking layer may include a heterocyclic compound.

本發明的有機發光裝置可更包括由下列各者所構成的族群中選出的一個、兩個或更多個層:發光層、電洞注入層、電洞轉移層、電子注入層、電子轉移層、電子阻擋層以及電洞阻擋層。 The organic light-emitting device of the present invention may further include one, two or more layers selected from the group consisting of: a light-emitting layer, a hole injection layer, a hole transfer layer, an electron injection layer, an electron transfer layer, an electron blocking layer and a hole blocking layer.

圖1至圖3說明根據本申請案之一個實施例的有機發光裝置之電極及有機材料層的層壓次序。然而,本申請案的範圍不 限於這些圖式,且本領域中已知的有機發光裝置的結構亦可用於本申請案中。 Figures 1 to 3 illustrate the lamination sequence of the electrode and the organic material layer of an organic light-emitting device according to an embodiment of the present application. However, the scope of the present application is not limited to these figures, and the structure of the organic light-emitting device known in the art can also be used in the present application.

圖1繪示了有機發光裝置,其中陽極200、有機材料層300以及陰極400連續層壓於基板100上。然而,所述結構不限於此類結構,且如圖2中所繪示的,亦可獲得有機發光裝置,其中陰極、有機材料層以及陽極連續層壓於基板上。 FIG. 1 shows an organic light-emitting device in which an anode 200, an organic material layer 300, and a cathode 400 are continuously laminated on a substrate 100. However, the structure is not limited to such a structure, and an organic light-emitting device can also be obtained in which a cathode, an organic material layer, and an anode are continuously laminated on a substrate as shown in FIG. 2.

圖3繪示了有機材料層為多層的情況。根據圖3之有機發光裝置包括電洞注入層301、電洞轉移層302、發光層303、電洞阻擋層304、電子轉移層305以及電子注入層306。然而,本申請案之範疇不限於此類層壓結構,且視需要,可不包含除發光層外的其他層,且可更包含其他必要功能層。 FIG3 shows a case where the organic material layer is multi-layered. The organic light-emitting device according to FIG3 includes a hole injection layer 301, a hole transfer layer 302, a light-emitting layer 303, a hole blocking layer 304, an electron transfer layer 305, and an electron injection layer 306. However, the scope of this application is not limited to such a laminated structure, and may not include other layers except the light-emitting layer as needed, and may further include other necessary functional layers.

視需要,包括化學式1至化學式9之有機材料層可更包括其他材料。 If necessary, the organic material layer including Chemical Formula 1 to Chemical Formula 9 may further include other materials.

另外,根據本申請案的一個實施例的有機發光裝置包括陽極、陰極以及設置於陽極與陰極之間的兩個或更多個堆疊,其中兩個或更多個堆疊各自獨立地包括發光層,電荷產生層包含於兩個或更多個堆疊之間,且電荷產生層包括由化學式1表示的雜環化合物。 In addition, an organic light-emitting device according to an embodiment of the present application includes an anode, a cathode, and two or more stacks disposed between the anode and the cathode, wherein the two or more stacks each independently include a light-emitting layer, a charge generating layer is included between the two or more stacks, and the charge generating layer includes a heterocyclic compound represented by Chemical Formula 1.

此外,根據本申請案之一個實施例的有機發光裝置可包括陽極、設置於陽極上且包括第一發光層之第一堆疊、設置於第一堆疊上之電荷產生層、設置於電荷產生層上且包括第二發光層之第二堆疊,以及設置於第二堆疊上之陰極。在本文中,電荷產生層可包括由化學式1表示之雜環化合物。另外,第一堆疊及第二堆疊可各自獨立地更包括上文所描述之一或多種類型的電洞注 入層、電洞轉移層、電洞阻擋層、電子轉移層、電子注入層以及類似者。 In addition, an organic light-emitting device according to an embodiment of the present application may include an anode, a first stack disposed on the anode and including a first light-emitting layer, a charge generation layer disposed on the first stack, a second stack disposed on the charge generation layer and including a second light-emitting layer, and a cathode disposed on the second stack. In this article, the charge generation layer may include a heterocyclic compound represented by Chemical Formula 1. In addition, the first stack and the second stack may each independently further include one or more types of hole injection layers, hole transfer layers, hole blocking layers, electron transfer layers, electron injection layers, and the like described above.

電荷產生層可為N型電荷產生層,且除由化學式1表示的雜環化合物以外,電荷產生層可更包括本領域中已知的摻雜劑。 The charge generating layer may be an N-type charge generating layer, and in addition to the heterocyclic compound represented by Chemical Formula 1, the charge generating layer may further include a dopant known in the art.

如根據本申請案之一個實施例的有機發光裝置,在圖4中示意性地說明具有2-堆疊串疊型結構之有機發光裝置。 For example, an organic light-emitting device according to one embodiment of the present application is schematically illustrated in FIG4 as an organic light-emitting device having a 2-stacked series structure.

在本文中,在一些情況下可不包含圖4中描述的第一電子阻擋層、第一電洞阻擋層及第二電洞阻擋層以及類似者。 In this article, the first electron blocking layer, the first hole blocking layer, the second hole blocking layer, and the like described in FIG. 4 may not be included in some cases.

在根據本申請案之一個實施例之有機發光裝置中,下文說明除化學式1至化學式9之化合物以外的材料,但是,這些材料僅用於說明之目的且並非限制本申請案之範疇,且可由本領域中已知的材料替換。 In an organic light-emitting device according to an embodiment of the present application, materials other than the compounds of Chemical Formulae 1 to 9 are described below, but these materials are only used for the purpose of description and do not limit the scope of the present application, and can be replaced by materials known in the art.

可使用具有相對較大功函數之材料作為陽極材料,且可使用透明之導電氧化物、金屬、導電聚合物或類似材料。陽極材料的具體實例包括:金屬,諸如釩、鉻、銅、鋅以及金,或其合金;金屬氧化物,諸如氧化鋅、氧化銦、氧化銦錫(ITO)以及氧化銦鋅(IZO);金屬與氧化物之組合,諸如ZnO:Al或SnO2:Sb;導電聚合物,諸如聚(3-甲基噻吩)、聚[3,4-(伸乙基-1,2-二氧基)噻吩](poly[3,4-(ethylene-1,2-dioxy)thiophene])(PEDOT)、聚吡咯以及聚苯胺及類似物,但不限於此。 A material having a relatively large work function may be used as the anode material, and a transparent conductive oxide, metal, conductive polymer or the like may be used. Specific examples of the anode material include: metals such as vanadium, chromium, copper, zinc and gold, or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO) and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO 2 :Sb; conductive polymers such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), polypyrrole and polyaniline and the like, but are not limited thereto.

可使用具有相對較小功函數之材料作為陰極材料,且可使用金屬、金屬氧化物、導電聚合物或類似材料。陰極材料之具體實例包括金屬,諸如鎂、鈣、鈉、鉀、鈦、銦、釔、鋰、釓、鋁、銀、錫以及鉛,或其合金;多層結構材料,諸如LiF/Al或LiO2/Al 及類似物,但不限於此。 A material having a relatively small work function may be used as the cathode material, and metal, metal oxide, conductive polymer or the like may be used. Specific examples of cathode materials include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead, or alloys thereof; multilayer structure materials such as LiF/Al or LiO2 /Al and the like, but are not limited thereto.

可使用已知的電洞注入材料作為電洞注入材料,且例如可使用酞菁化合物,諸如美國專利第4,356,429號中所揭露之銅酞菁;或星爆式胺衍生物,諸如描述於文獻[高級材料(Advanced Material),6,第677頁(1994)]中之三(4-肼甲醯基-9-基苯基)胺(TCTA)、4,4',4"-三[苯基(間甲苯基)胺基]三苯胺(間MTDATA)或1,3,5-三[4-(3-甲基苯基苯基胺基)苯基]苯(間MTDAPB);具有溶解度之導電聚合物,聚苯胺/十二烷基苯磺酸、聚(3,4-伸乙二氧基噻吩)/聚(4-苯乙烯磺酸脂)、聚苯胺/樟腦磺酸(dodecylbenzene sulfonic acid)或聚苯胺/聚(4-苯乙烯-磺酸酯);以及類似材料。 As the hole injection material, a known hole injection material can be used, and for example, a phthalocyanine compound such as copper phthalocyanine disclosed in U.S. Patent No. 4,356,429 can be used; or a starburst amine derivative such as tris(4-hydrazinemethylyl-9-ylphenyl)amine (TCTA), 4,4',4"-tris[phenyl(m-tolyl)amino]triphenylamine (m-MTDATA) or 1,3,5-tris[4-(3-methylphenylphenylamino)phenyl]benzene (m-MTDAPB) described in the literature [Advanced Material, 6, p. 677 (1994)]; a conductive polymer having solubility, polyaniline/dodecylbenzene sulfonic acid, poly(3,4-ethylenedioxythiophene)/poly(4-styrene sulfonic acid), polyaniline/camphor sulfonic acid (dodecylbenzene sulfonic acid) acid) or polyaniline/poly(4-styrene-sulfonate); and similar materials.

可使用吡唑啉衍生物、芳胺類衍生物、二苯乙烯衍生物、三苯基二胺衍生物以及類似材料作為電洞轉移材料,且亦可使用低分子或高分子材料。 Pyrazoline derivatives, aromatic amine derivatives, stilbene derivatives, triphenyldiamine derivatives and similar materials can be used as hole transfer materials, and low molecular weight or high molecular weight materials can also be used.

可使用噁二唑衍生物之金屬錯合物、蒽醌二甲烷以及其衍生物、苯醌以及其衍生物、萘醌以及其衍生物、蒽醌以及其衍生物、四氰蒽醌二甲烷以及其衍生物、茀酮衍生物、二苯基二氰乙烯以及其衍生物、聯苯醌衍生物、8-羥基喹啉以及其衍生物、以及類似材料,且亦可使用高分子材料以及低分子材料作為電子轉移材料。 Metal complexes of oxadiazole derivatives, anthraquinone dimethane and its derivatives, benzoquinone and its derivatives, naphthoquinone and its derivatives, anthraquinone and its derivatives, tetracyanoanthraquinone dimethane and its derivatives, fluorenone derivatives, diphenyl dicyanoethylene and its derivatives, diphenoquinone derivatives, 8-hydroxyquinoline and its derivatives, and similar materials can be used, and polymer materials and low molecular weight materials can also be used as electron transfer materials.

作為電子注入材料之實例,LiF通常用於本領域中,然而,本申請案不限於此。 As an example of an electron injection material, LiF is generally used in this field, however, the present application is not limited thereto.

可使用發紅光、綠光或藍光之材料作為發光材料,且視需要可混合並使用兩種或更多種發光材料。在本文中,兩種或更多種發光材料可藉由沉積為個別供應源或藉由預混合及沉積為一 個供應源而使用。此外,亦可使用螢光材料作為發光材料,然而,亦可使用磷光材料。可單獨使用藉由使分別自陽極及陰極注入之電子及電洞鍵結來發光之材料作為發光材料,然而,亦可使用具有主體材料以及摻雜材料(同時參與發光)之材料。 As the light-emitting material, a material emitting red, green or blue light can be used, and two or more light-emitting materials can be mixed and used as needed. In this article, two or more light-emitting materials can be used by depositing as individual supply sources or by pre-mixing and depositing as one supply source. In addition, a fluorescent material can also be used as the light-emitting material, however, a phosphorescent material can also be used. As the light-emitting material, a material that emits light by bonding electrons and holes injected from the anode and the cathode, respectively, can be used alone, however, a material having a main material and a doped material (which simultaneously participates in light emission) can also be used.

當混合發光材料主體時,可混合相同系列主體,或可混合不同系列主體。舉例而言,可選擇n型主體材料或p型主體材料中的任何兩種或更多種類型的材料,且用作發光層的主體材料。 When mixing the host of light-emitting materials, the same series of hosts may be mixed, or different series of hosts may be mixed. For example, any two or more types of materials of n-type host materials or p-type host materials may be selected and used as the host material of the light-emitting layer.

取決於所用之材料,根據本申請案之一個實施例的有機發光裝置可為頂部發光型、底部發光型或雙面發光型。 Depending on the materials used, the organic light-emitting device according to one embodiment of the present application may be a top-emitting type, a bottom-emitting type, or a double-sided emitting type.

根據本申請案的一個實施例的雜環化合物亦可在用於有機發光裝置中的類似原理下用於有機電子裝置中,所述有機電子裝置包括有機太陽能電池、有機光導體、有機電晶體以及類似物。 The heterocyclic compound according to one embodiment of the present application can also be used in organic electronic devices under similar principles as used in organic light-emitting devices, including organic solar cells, organic photoconductors, organic transistors, and the like.

在下文中,本說明書將參照實例更詳細地進行描述,然而,這些僅用於說明之目的,且本申請案之範圍不限於此。 In the following, this specification will be described in more detail with reference to examples, however, these are for illustrative purposes only and the scope of this application is not limited thereto.

<製備實例><Preparation Example>

<製備實例1>製備化合物1<Preparation Example 1> Preparation of Compound 1

Figure 107134589-A0305-02-0050-47
Figure 107134589-A0305-02-0050-47

1)製備化合物1-11) Preparation of compound 1-1

在將(1H-吲哚-2-基)硼酸(100公克,0.621莫耳)及2-溴苯胺(2-bromoaniline)(96公克,0.558莫耳)溶解於甲苯、EtOH以及H2O(1000毫升:200毫升:200毫升)中之後,向其中引入Pd(PPh3)4(35.8公克,0.031莫耳)及NaHCO3(156.5公克,1.863莫耳),並在100℃下將所得物攪拌3小時。在反應完成之後,將二氯甲烷(methylene chloride;MC)及蒸餾水引入反應溶液中以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得呈液體形式之化合物1-1(94公克,72%)。 After (1H-indol-2-yl)boronic acid (100 g, 0.621 mol) and 2-bromoaniline (96 g, 0.558 mol) were dissolved in toluene, EtOH and H 2 O (1000 ml: 200 ml: 200 ml), Pd(PPh 3 ) 4 (35.8 g, 0.031 mol) and NaHCO 3 (156.5 g, 1.863 mol) were introduced thereto, and the resultant was stirred at 100° C. for 3 hours. After the reaction was completed, methylene chloride (MC) and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain Compound 1-1 (94 g, 72%) in the form of a liquid.

2)製備化合物1-22) Preparation of compound 1-2

將化合物1-1(94公克,0.451莫耳)及三乙胺(42毫升,0.451莫耳)引入至MC(1200毫升)並溶解於其中。在0℃下將溶解於MC(300毫升)中之4-溴苯甲醯氯(4-Bromobenzoyl chloride)(108.9公克,0.496莫耳)緩慢地逐滴添加至混合物。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得呈液體形式之化合物1-2(150公克,85%)。 Compound 1-1 (94 g, 0.451 mol) and triethylamine (42 ml, 0.451 mol) were introduced into MC (1200 ml) and dissolved therein. 4-Bromobenzoyl chloride (108.9 g, 0.496 mol) dissolved in MC (300 ml) was slowly added dropwise to the mixture at 0°C. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried with anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 1-2 (150 g, 85%) in liquid form.

3)製備化合物1-33) Preparation of compound 1-3

在將化合物1-2(150公克,0.383莫耳)溶解於硝基苯(1500毫升)中之後,向其中緩慢地逐滴添加POCl3(35毫升,0.383莫耳)。使所得物在140℃下反應15小時。在反應完成之後,將使NaHCO3溶解於蒸餾水中之溶液緩慢引入至反應溶液,且攪拌所得物。過濾生成之固體並進行收集。用MC及MeOH使所收集之固體再結晶,以獲得呈固體形式之化合物1-3(68公克,48%)。 After compound 1-2 (150 g, 0.383 mol) was dissolved in nitrobenzene (1500 mL), POCl 3 (35 mL, 0.383 mol) was slowly added dropwise thereto. The resultant was reacted at 140° C. for 15 hours. After the reaction was completed, a solution in which NaHCO 3 was dissolved in distilled water was slowly introduced into the reaction solution, and the resultant was stirred. The generated solid was filtered and collected. The collected solid was recrystallized with MC and MeOH to obtain compound 1-3 (68 g, 48%) in the form of a solid.

4)製備化合物1-44) Preparation of Compound 1-4

在將化合物1-3(10公克,0.026莫耳)、雙(頻哪醇根基)二硼(bis(pinacolato)diboron)(9.9公克,0.039莫耳)、KOAc(7.6公克,0.078莫耳)以及PdCl2(dppf)(0.9公克,0.0013莫耳)溶解於1,4-二噁烷(200毫升)中之後,使所得物在90℃下反應5小時。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得化合物1-4(10公克,91%) After dissolving compound 1-3 (10 g, 0.026 mol), bis(pinacolato)diboron (9.9 g, 0.039 mol), KOAc (7.6 g, 0.078 mol) and PdCl 2 (dppf) (0.9 g, 0.0013 mol) in 1,4-dioxane (200 ml), the resultant was reacted at 90° C. for 5 hours. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried with anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 1-4 (10 g, 91%)

5)製備化合物1-55) Preparation of Compound 1-5

在將化合物1-4(10公克,0.023莫耳)及2-溴-4,6-二苯基-1,3,5-三嗪(2-bromo-4,6-diphenyl-1,3,5-triazine)(7公克,0.023莫耳)溶解於甲苯、EtOH以及H2O(100毫升:20毫升:20毫升)中之後,向其中引入Pd(PPh3)4(1.3公克,0.0011莫耳)及K2CO3(9.5公克,0.069莫耳),且在100℃下將所得物攪拌5小時。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得化合物1-5(9公克,74%) After compound 1-4 (10 g, 0.023 mol) and 2-bromo-4,6-diphenyl-1,3,5-triazine (7 g, 0.023 mol) were dissolved in toluene, EtOH and H 2 O (100 ml: 20 ml: 20 ml), Pd(PPh 3 ) 4 (1.3 g, 0.0011 mol) and K 2 CO 3 (9.5 g, 0.069 mol) were introduced thereto, and the resultant was stirred at 100° C. for 5 hours. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried with anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 1-5 (9 g, 74%)

6)製備化合物16) Preparation of compound 1

在將化合物1-5(9公克,0.017莫耳)及溴苯(3.2公克,0.021莫耳)溶解於甲苯(100毫升)中之後,向其中引入Pd2(dba)3(1.5公克,0.0017莫耳)、三-第三丁基膦(0.6公克,0.034莫耳)以及第三丁醇鈉(4.9公克,0.051莫耳),且在100℃下將所得物攪拌15小時。在反應完成後,將所得物冷卻至室溫,且過濾生成的固體並乾燥以獲得化合物1(7.5公克,73%)。 After compound 1-5 (9 g, 0.017 mol) and bromobenzene (3.2 g, 0.021 mol) were dissolved in toluene (100 ml), Pd 2 (dba) 3 (1.5 g, 0.0017 mol), tri-tert-butylphosphine (0.6 g, 0.034 mol) and sodium tert-butoxide (4.9 g, 0.051 mol) were introduced thereto, and the resultant was stirred at 100° C. for 15 hours. After the reaction was completed, the resultant was cooled to room temperature, and the generated solid was filtered and dried to obtain compound 1 (7.5 g, 73%).

除了使用下表1的中間物A代替2-溴-4,6-二苯基-1,3,5-三嗪之外,以與製備實例1中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 1, except that the intermediate A in Table 1 below was used instead of 2-bromo-4,6-diphenyl-1,3,5-triazine.

Figure 107134589-A0305-02-0053-48
Figure 107134589-A0305-02-0053-48
Figure 107134589-A0305-02-0054-49
Figure 107134589-A0305-02-0054-49
Figure 107134589-A0305-02-0055-50
Figure 107134589-A0305-02-0055-50
Figure 107134589-A0305-02-0056-51
Figure 107134589-A0305-02-0056-51
Figure 107134589-A0305-02-0057-53
Figure 107134589-A0305-02-0057-53
Figure 107134589-A0305-02-0058-54
Figure 107134589-A0305-02-0058-54
Figure 107134589-A0305-02-0059-57
Figure 107134589-A0305-02-0059-57

除了使用下表2的中間物B代替4-溴苯甲醯氯及使用下表2之中間物C代替2-溴-4,6-二苯基-1,3,5-三嗪之外,以與製備實例1中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 1, except that the intermediate B in Table 2 below was used instead of 4-bromobenzyl chloride and the intermediate C in Table 2 below was used instead of 2-bromo-4,6-diphenyl-1,3,5-triazine.

Figure 107134589-A0305-02-0059-58
Figure 107134589-A0305-02-0059-58
Figure 107134589-A0305-02-0060-59
Figure 107134589-A0305-02-0060-59
Figure 107134589-A0305-02-0061-60
Figure 107134589-A0305-02-0061-60

除了使用下表3之中間物D代替2-溴苯胺且使用下表3之中間物E代替2-溴-4,6-二苯基-1,3,5-三嗪以外,以與製備實例1中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 1, except that the intermediate D in Table 3 below was used instead of 2-bromoaniline and the intermediate E in Table 3 below was used instead of 2-bromo-4,6-diphenyl-1,3,5-triazine.

Figure 107134589-A0305-02-0061-61
Figure 107134589-A0305-02-0061-61
Figure 107134589-A0305-02-0062-63
Figure 107134589-A0305-02-0062-63

<製備實例2>製備化合物135 <Preparation Example 2> Preparation of Compound 135

Figure 107134589-A0305-02-0062-64
Figure 107134589-A0305-02-0062-64

1)製備化合物135-11) Preparation of compound 135-1

在將(1H-吲哚-2-基)硼酸(100公克,0.621莫耳)及2-溴苯胺(2-bromoaniline)(96公克,0.558莫耳)溶解於甲苯、EtOH以及H2O(1000毫升:200毫升:200毫升)中之後,向其中引入Pd(PPh3)4(35.8公克,0.031莫耳)及NaHCO3(156.5公克,1.863莫耳),並在100℃下將所得物攪拌3小時。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得呈液體形式之化合物135-1(94公克,72%)。 After (1H-indol-2-yl)boronic acid (100 g, 0.621 mol) and 2-bromoaniline (96 g, 0.558 mol) were dissolved in toluene, EtOH and H 2 O (1000 ml: 200 ml: 200 ml), Pd(PPh 3 ) 4 (35.8 g, 0.031 mol) and NaHCO 3 (156.5 g, 1.863 mol) were introduced thereto, and the resultant was stirred at 100° C. for 3 hours. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried with anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 135-1 (94 g, 72%) in liquid form.

2)製備化合物135-22) Preparation of compound 135-2

將化合物135-1(94公克,0.451莫耳)及三乙胺(42毫升,0.451莫耳)引入至MC(1200毫升)並溶解於其中。在0℃ 下將溶解於MC(300毫升)中之苯甲醯氯(Benzoyl chloride)(69.7公克,0.496莫耳)緩慢地逐滴添加至混合物。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得呈液體形式之化合物135-2(112公克,80%)。 Compound 135-1 (94 g, 0.451 mol) and triethylamine (42 ml, 0.451 mol) were introduced into MC (1200 ml) and dissolved therein. Benzoyl chloride (69.7 g, 0.496 mol) dissolved in MC (300 ml) was slowly added dropwise to the mixture at 0°C. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 135-2 (112 g, 80%) in liquid form.

3)製備化合物135-33) Preparation of compound 135-3

在將化合物135-2(112公克,0.358莫耳)溶解於硝基苯(1000毫升)中之後,向其中緩慢地逐滴添加POCl3(33毫升,0.358莫耳)。使所得物在140℃下反應15小時。在反應完成之後,將使NaHCO3溶解於蒸餾水中之溶液緩慢引入至反應溶液,且攪拌所得物。過濾生成之固體並進行收集。用MC及MeOH使所收集之固體再結晶,以獲得呈固體形式之化合物135-3(54公克,51%)。 After compound 135-2 (112 g, 0.358 mol) was dissolved in nitrobenzene (1000 mL), POCl 3 (33 mL, 0.358 mol) was slowly added dropwise thereto. The resultant was reacted at 140° C. for 15 hours. After the reaction was completed, a solution in which NaHCO 3 was dissolved in distilled water was slowly introduced into the reaction solution, and the resultant was stirred. The generated solid was filtered and collected. The collected solid was recrystallized with MC and MeOH to obtain compound 135-3 (54 g, 51%) in the form of a solid.

4)製備化合物1354) Preparation of compound 135

在將化合物135-3(9公克,0.030莫耳)及4-(4-溴苯基)-2,6-二苯基嘧啶(4-(4-bromophenyl)-2,6-diphenylpyrimidine)(11.8公克,0.030莫耳)溶解於甲苯(100毫升)中之後,向其中引入Pd2(dba)3(2.8公克,0.003莫耳)、三-第三丁基膦(1.2公克,0.006莫耳)以及第三丁醇鈉(5.7公克,0.062莫耳),且在100℃下將所得物攪拌15小時。在反應完成後,將所得物冷卻至室溫,且過濾生成的固體並乾燥以獲得化合物135(9.4公克,52%)。 After compound 135-3 (9 g, 0.030 mol) and 4-(4-bromophenyl)-2,6-diphenylpyrimidine (11.8 g, 0.030 mol) were dissolved in toluene (100 ml), Pd 2 (dba) 3 (2.8 g, 0.003 mol), tri-tert-butylphosphine (1.2 g, 0.006 mol) and sodium tert-butoxide (5.7 g, 0.062 mol) were introduced thereto, and the resultant was stirred at 100° C. for 15 hours. After the reaction was completed, the resultant was cooled to room temperature, and the generated solid was filtered and dried to obtain compound 135 (9.4 g, 52%).

除了使用下表4的中間物F代替4-(4-溴苯基)-2,6-二苯基嘧啶之外,以與製備實例2中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 2, except that the intermediate F in Table 4 below was used instead of 4-(4-bromophenyl)-2,6-diphenylpyrimidine.

Figure 107134589-A0305-02-0063-65
Figure 107134589-A0305-02-0063-65
Figure 107134589-A0305-02-0064-66
Figure 107134589-A0305-02-0064-66
Figure 107134589-A0305-02-0065-67
Figure 107134589-A0305-02-0065-67
Figure 107134589-A0305-02-0066-68
Figure 107134589-A0305-02-0066-68
Figure 107134589-A0305-02-0067-69
Figure 107134589-A0305-02-0067-69
Figure 107134589-A0305-02-0068-70
Figure 107134589-A0305-02-0068-70
Figure 107134589-A0305-02-0069-71
Figure 107134589-A0305-02-0069-71

除了使用下表5之中間物G代替苯甲醯氯及使用下表5之中間物H代替4-(4-溴苯基)-2,6-二苯基嘧啶之外,以與製備實例2中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 2, except that the intermediate G in Table 5 below was used instead of benzoyl chloride and the intermediate H in Table 5 below was used instead of 4-(4-bromophenyl)-2,6-diphenylpyrimidine.

Figure 107134589-A0305-02-0069-74
Figure 107134589-A0305-02-0069-74
Figure 107134589-A0305-02-0070-75
Figure 107134589-A0305-02-0070-75
Figure 107134589-A0305-02-0071-76
Figure 107134589-A0305-02-0071-76

除了使用下表6之中間物I代替2-溴苯胺及使用下表6之中間物J代替4-(4-溴苯基)-2,6-二苯基嘧啶之外,以與製備實例2中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 2, except that the intermediate I in Table 6 below was used instead of 2-bromoaniline and the intermediate J in Table 6 below was used instead of 4-(4-bromophenyl)-2,6-diphenylpyrimidine.

Figure 107134589-A0305-02-0071-77
Figure 107134589-A0305-02-0071-77
Figure 107134589-A0305-02-0072-78
Figure 107134589-A0305-02-0072-78

<製備實例3>製備化合物237<Preparation Example 3> Preparation of Compound 237

Figure 107134589-A0305-02-0072-79
Figure 107134589-A0305-02-0072-79

1)製備化合物237-11) Preparation of compound 237-1

在將(1H-吲哚-3-基)硼酸(100公克,0.621莫耳)及2-溴苯胺(2-bromoaniline)(96公克,0.558莫耳)溶解於甲苯、EtOH以及H2O(1000毫升:200毫升:200毫升)中之後,向其中引入Pd(PPh3)4(35.8公克,0.031莫耳)及NaHCO3(156.5公克,1.863莫耳),並在100℃下將所得物攪拌3小時。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得呈液體形式之化合物237-1(94公克,72%)。 After (1H-indol-3-yl)boronic acid (100 g, 0.621 mol) and 2-bromoaniline (96 g, 0.558 mol) were dissolved in toluene, EtOH and H 2 O (1000 ml: 200 ml: 200 ml), Pd(PPh 3 ) 4 (35.8 g, 0.031 mol) and NaHCO 3 (156.5 g, 1.863 mol) were introduced thereto, and the resultant was stirred at 100° C. for 3 hours. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried with anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 237-1 (94 g, 72%) in liquid form.

2)製備化合物237-22) Preparation of compound 237-2

將化合物237-1(94公克,0.451莫耳)及三乙胺(42毫 升,0.451莫耳)引入至MC(1200毫升)並溶解於其中。在0℃下將溶解於MC(300毫升)中之4-溴苯甲醯氯(4-Bromobenzoyl chloride)(108.9公克,0.496莫耳)緩慢地逐滴添加至混合物。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得呈液體形式之化合物237-2(150公克,85%)。 Compound 237-1 (94 g, 0.451 mol) and triethylamine (42 ml, 0.451 mol) were introduced into MC (1200 ml) and dissolved therein. 4-Bromobenzoyl chloride (108.9 g, 0.496 mol) dissolved in MC (300 ml) was slowly added dropwise to the mixture at 0°C. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 237-2 (150 g, 85%) in liquid form.

3)製備化合物237-33) Preparation of compound 237-3

在將化合物237-2(150公克,0.383莫耳)溶解於硝基苯(1500毫升)中之後,向其中緩慢地逐滴添加POCl3(35毫升,0.383莫耳)。使所得物在140℃下反應15小時。在反應完成之後,將使NaHCO3溶解於蒸餾水中之溶液緩慢引入至反應溶液,且攪拌所得物。過濾生成之固體並進行收集。用MC及MeOH使所收集之固體再結晶,以獲得呈固體形式之化合物237-3(68公克,48%)。 After compound 237-2 (150 g, 0.383 mol) was dissolved in nitrobenzene (1500 ml), POCl 3 (35 ml, 0.383 mol) was slowly added dropwise thereto. The resultant was reacted at 140° C. for 15 hours. After the reaction was completed, a solution in which NaHCO 3 was dissolved in distilled water was slowly introduced into the reaction solution, and the resultant was stirred. The generated solid was filtered and collected. The collected solid was recrystallized with MC and MeOH to obtain compound 237-3 (68 g, 48%) in the form of a solid.

4)製備化合物237-44) Preparation of compound 237-4

在將化合物237-3(10公克,0.026莫耳)、雙(頻哪醇根基)二硼(bis(pinacolato)diboron)(9.9公克,0.039莫耳)、KOAc(7.6公克,0.078莫耳)以及PdCl2(dppf)(0.9公克,0.0013莫耳)溶解於1,4-二噁烷(200毫升)中之後,使所得物在90℃下反應5小時。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得化合物237-4(10公克,91%) After dissolving compound 237-3 (10 g, 0.026 mol), bis(pinacolato)diboron (9.9 g, 0.039 mol), KOAc (7.6 g, 0.078 mol) and PdCl 2 (dppf) (0.9 g, 0.0013 mol) in 1,4-dioxane (200 ml), the resultant was reacted at 90° C. for 5 hours. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried with anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 237-4 (10 g, 91%)

5)製備化合物237-55) Preparation of compound 237-5

在將化合物237-4(8公克,0.019莫耳)及2-溴-4,6-二 苯基-1,3,5-三嗪(2-bromo-4,6-diphenyl-1,3,5-triazine)(5.9公克,0.019莫耳)溶解於甲苯、EtOH以及H2O(80毫升:10毫升:10毫升)中之後,向其中引入Pd(PPh3)4(1.1公克,0.0009莫耳)及K2CO3(7.8公克,0.057莫耳),且在100℃下將所得物攪拌5小時。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得化合物237-5(7.4公克,75%)。 After compound 237-4 (8 g, 0.019 mol) and 2-bromo-4,6-diphenyl-1,3,5-triazine (5.9 g, 0.019 mol) were dissolved in toluene, EtOH and H 2 O (80 ml: 10 ml: 10 ml), Pd(PPh 3 ) 4 (1.1 g, 0.0009 mol) and K 2 CO 3 (7.8 g, 0.057 mol) were introduced thereto, and the resultant was stirred at 100° C. for 5 hours. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 237-5 (7.4 g, 75%).

6)製備化合物2376) Preparation of compound 237

在將化合物237-5(7.4公克,0.014莫耳)及溴苯(3.2公克,0.021莫耳)溶解於甲苯(100毫升)中之後,向其中引入Pd2(dba)3(1.2公克,0.0014莫耳)、三-第三丁基膦(0.5公克,0.0028莫耳)以及第三丁醇鈉(2.7公克,0.028莫耳),且在100℃下將所得物攪拌15小時。在反應完成後,將所得物冷卻至室溫,且過濾生成的固體並乾燥以獲得化合物237(6.5公克,77%)。 After compound 237-5 (7.4 g, 0.014 mol) and bromobenzene (3.2 g, 0.021 mol) were dissolved in toluene (100 ml), Pd 2 (dba) 3 (1.2 g, 0.0014 mol), tri-tert-butylphosphine (0.5 g, 0.0028 mol) and sodium tert-butoxide (2.7 g, 0.028 mol) were introduced thereto, and the resultant was stirred at 100° C. for 15 hours. After the reaction was completed, the resultant was cooled to room temperature, and the generated solid was filtered and dried to obtain compound 237 (6.5 g, 77%).

除了使用下表7的中間物K代替2-溴-4,6-二苯基-1,3,5-三嗪之外,以與製備實例3中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 3, except that the intermediate K in Table 7 below was used instead of 2-bromo-4,6-diphenyl-1,3,5-triazine.

Figure 107134589-A0305-02-0074-80
Figure 107134589-A0305-02-0074-80
Figure 107134589-A0305-02-0075-82
Figure 107134589-A0305-02-0075-82
Figure 107134589-A0305-02-0076-83
Figure 107134589-A0305-02-0076-83
Figure 107134589-A0305-02-0077-85
Figure 107134589-A0305-02-0077-85
Figure 107134589-A0305-02-0078-86
Figure 107134589-A0305-02-0078-86
Figure 107134589-A0305-02-0079-87
Figure 107134589-A0305-02-0079-87
Figure 107134589-A0305-02-0080-88
Figure 107134589-A0305-02-0080-88

除了使用下表8的中間物L代替4-溴苯甲醯氯及使用下表8之中間物M代替2-溴-4,6-二苯基-1,3,5-三嗪之外,以與製備實例3中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 3, except that the intermediate L in Table 8 below was used instead of 4-bromobenzyl chloride and the intermediate M in Table 8 below was used instead of 2-bromo-4,6-diphenyl-1,3,5-triazine.

Figure 107134589-A0305-02-0080-89
Figure 107134589-A0305-02-0080-89
Figure 107134589-A0305-02-0081-90
Figure 107134589-A0305-02-0081-90
Figure 107134589-A0305-02-0082-92
Figure 107134589-A0305-02-0082-92

除了使用下表9的中間物N代替2-溴苯胺及使用下表9之中間物O代替2-溴-4,6-二苯基-1,3,5-三嗪之外,以與製備實例3中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 3, except that the intermediate N in Table 9 below was used instead of 2-bromoaniline and the intermediate O in Table 9 below was used instead of 2-bromo-4,6-diphenyl-1,3,5-triazine.

Figure 107134589-A0305-02-0082-93
Figure 107134589-A0305-02-0082-93

<製備實例4>製備化合物345<Preparation Example 4> Preparation of Compound 345

Figure 107134589-A0305-02-0083-95
Figure 107134589-A0305-02-0083-95

1)製備化合物345-11) Preparation of compound 345-1

在將(1H-吲哚-3-基)硼酸(100公克,0.621莫耳)及2-溴苯胺(2-bromoaniline)(96公克,0.558莫耳)溶解於甲苯、EtOH以及H2O(1000毫升:200毫升:200毫升)中之後,向其中引入Pd(PPh3)4(35.8公克,0.031莫耳)及NaHCO3(156.5公克,1.863莫耳),並在100℃下將所得物攪拌3小時。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得呈液體形式之化合物345-1(94公克,72%)。 After (1H-indol-3-yl)boronic acid (100 g, 0.621 mol) and 2-bromoaniline (96 g, 0.558 mol) were dissolved in toluene, EtOH and H 2 O (1000 ml: 200 ml: 200 ml), Pd(PPh 3 ) 4 (35.8 g, 0.031 mol) and NaHCO 3 (156.5 g, 1.863 mol) were introduced thereto, and the resultant was stirred at 100° C. for 3 hours. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried with anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 345-1 (94 g, 72%) in liquid form.

2)製備化合物345-22) Preparation of compound 345-2

將化合物345-1(94公克,0.451莫耳)及三乙胺(42毫升,0.451莫耳)引入至MC(1200毫升)並溶解於其中。在0℃下將溶解於MC(300毫升)中之苯甲醯氯(Benzoyl chloride)(69.7公克,0.496莫耳)緩慢地逐滴添加至混合物。在反應完成之後,將MC及蒸餾水引入反應溶液以供萃取。此後,用無水MgSO4乾燥所得物,且使用旋轉式蒸發器移除溶劑以獲得呈液體形式之化合物345-2(112公克,80%)。 Compound 345-1 (94 g, 0.451 mol) and triethylamine (42 ml, 0.451 mol) were introduced into MC (1200 ml) and dissolved therein. Benzoyl chloride (69.7 g, 0.496 mol) dissolved in MC (300 ml) was slowly added dropwise to the mixture at 0°C. After the reaction was completed, MC and distilled water were introduced into the reaction solution for extraction. Thereafter, the resultant was dried over anhydrous MgSO 4 , and the solvent was removed using a rotary evaporator to obtain compound 345-2 (112 g, 80%) in liquid form.

3)製備化合物345-33) Preparation of compound 345-3

在將化合物345-2(112公克,0.358莫耳)溶解於硝基苯 (1000毫升)中之後,向其中緩慢地逐滴添加POCl3(33毫升,0.358莫耳)。使所得物在140℃下反應15小時。在反應完成之後,將使NaHCO3溶解於蒸餾水中之溶液緩慢引入至反應溶液,且攪拌所得物。過濾生成之固體並進行收集。用MC及MeOH使所收集之固體再結晶,以獲得呈固體形式之化合物345-3(54公克,51%)。 After compound 345-2 (112 g, 0.358 mol) was dissolved in nitrobenzene (1000 mL), POCl 3 (33 mL, 0.358 mol) was slowly added dropwise thereto. The resultant was reacted at 140° C. for 15 hours. After the reaction was completed, a solution in which NaHCO 3 was dissolved in distilled water was slowly introduced into the reaction solution, and the resultant was stirred. The generated solid was filtered and collected. The collected solid was recrystallized with MC and MeOH to obtain compound 345-3 (54 g, 51%) in the form of a solid.

4)製備化合物3454) Preparation of compound 345

在將化合物345-3(9公克,0.030莫耳)、2,4-二([1,1'-聯苯]-4-基)-6-(4-溴苯基)嘧啶(2,4-di([1,1’-biphenyl]-4-yl)-6-(4-bromophenyl)pyrimidine)(4.7公克,0.030莫耳)溶解於甲苯(100毫升)中之後,向其中引入Pd2(dba)3(2.8公克,0.003莫耳)、三-第三丁基膦(1.2公克,0.006莫耳)以及第三丁醇鈉(5.7公克,0.062莫耳),且在100℃下將所得物攪拌15小時。在反應完成後,將所得物冷卻至室溫,且過濾生成的固體並乾燥以獲得化合物345(15公克,60%)。 After compound 345-3 (9 g, 0.030 mol) and 2,4-di([1,1'-biphenyl]-4-yl)-6-(4-bromophenyl)pyrimidine (4.7 g, 0.030 mol) were dissolved in toluene (100 ml), Pd 2 (dba) 3 (2.8 g, 0.003 mol), tri-tert-butylphosphine (1.2 g, 0.006 mol) and sodium tert-butoxide (5.7 g, 0.062 mol) were introduced thereto, and the resultant was stirred at 100° C. for 15 hours. After the reaction was completed, the resultant was cooled to room temperature, and the resulting solid was filtered and dried to obtain Compound 345 (15 g, 60%).

除了使用下表10的中間物P代替2,4-二([1,1'-聯苯]-4-基)-6-(4-溴苯基)嘧啶之外,以與製備實例4中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 4, except that the intermediate P in Table 10 below was used instead of 2,4-di([1,1'-biphenyl]-4-yl)-6-(4-bromophenyl)pyrimidine.

Figure 107134589-A0305-02-0084-96
Figure 107134589-A0305-02-0084-96
Figure 107134589-A0305-02-0085-97
Figure 107134589-A0305-02-0085-97
Figure 107134589-A0305-02-0086-98
Figure 107134589-A0305-02-0086-98
Figure 107134589-A0305-02-0087-99
Figure 107134589-A0305-02-0087-99
Figure 107134589-A0305-02-0088-100
Figure 107134589-A0305-02-0088-100
Figure 107134589-A0305-02-0089-101
Figure 107134589-A0305-02-0089-101

除了使用下表11之中間物Q代替苯甲醯氯且使用下表11之中間物R代替2,4-二([1,1'-聯苯]-4-基)-6-(4-溴苯基)嘧啶以外,以與製備實例4中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 4, except that the intermediate Q in Table 11 below was used instead of benzoyl chloride and the intermediate R in Table 11 below was used instead of 2,4-di([1,1'-biphenyl]-4-yl)-6-(4-bromophenyl)pyrimidine.

Figure 107134589-A0305-02-0089-102
Figure 107134589-A0305-02-0089-102
Figure 107134589-A0305-02-0090-103
Figure 107134589-A0305-02-0090-103

除了使用下表12之中間物S代替2-溴苯胺且使用下表12之中間物T代替2,4-二([1,1'-聯苯]-4-基)-6-(4-溴苯基)嘧啶以外,以與製備實例4中相同的方式合成目標化合物。 The target compound was synthesized in the same manner as in Preparation Example 4, except that the intermediate S in Table 12 below was used instead of 2-bromoaniline and the intermediate T in Table 12 below was used instead of 2,4-di([1,1'-biphenyl]-4-yl)-6-(4-bromophenyl)pyrimidine.

Figure 107134589-A0305-02-0090-104
Figure 107134589-A0305-02-0090-104
Figure 107134589-A0305-02-0091-105
Figure 107134589-A0305-02-0091-105

亦與上文所描述之製備實例中相同的方式製備除了表1至表12中所描述之化合物以外的化合物。 Compounds other than the compounds described in Tables 1 to 12 were also prepared in the same manner as in the preparation examples described above.

下表13及表14呈現經合成化合物之1H NMR資料及FD-MS資料,且經由以下資料,可識別目標化合物之合成。 Tables 13 and 14 below present the 1H NMR data and FD-MS data of the synthesized compounds, and the synthesis of the target compound can be identified through the following data.

Figure 107134589-A0305-02-0091-106
Figure 107134589-A0305-02-0091-106
Figure 107134589-A0305-02-0092-108
Figure 107134589-A0305-02-0092-108
Figure 107134589-A0305-02-0093-109
Figure 107134589-A0305-02-0093-109
Figure 107134589-A0305-02-0094-110
Figure 107134589-A0305-02-0094-110
Figure 107134589-A0305-02-0095-111
Figure 107134589-A0305-02-0095-111
Figure 107134589-A0305-02-0096-112
Figure 107134589-A0305-02-0096-112
Figure 107134589-A0305-02-0097-113
Figure 107134589-A0305-02-0097-113
Figure 107134589-A0305-02-0098-114
Figure 107134589-A0305-02-0098-114

Figure 107134589-A0305-02-0098-116
Figure 107134589-A0305-02-0098-116
Figure 107134589-A0305-02-0099-117
Figure 107134589-A0305-02-0099-117
Figure 107134589-A0305-02-0100-118
Figure 107134589-A0305-02-0100-118
Figure 107134589-A0305-02-0101-119
Figure 107134589-A0305-02-0101-119
Figure 107134589-A0305-02-0102-121
Figure 107134589-A0305-02-0102-121
Figure 107134589-A0305-02-0103-123
Figure 107134589-A0305-02-0103-123
Figure 107134589-A0305-02-0104-124
Figure 107134589-A0305-02-0104-124
Figure 107134589-A0305-02-0105-125
Figure 107134589-A0305-02-0105-125
Figure 107134589-A0305-02-0106-126
Figure 107134589-A0305-02-0106-126

<實驗實例1>製造有機發光裝置<Experimental Example 1> Manufacturing of an organic light-emitting device

1)製造有機發光裝置1) Manufacturing of organic light-emitting devices

將自用於OLED的玻璃(由三星康寧有限公司(Samsung-Corning Co.,Ltd.)製造)獲得的透明ITO電極薄膜各自使用三氯乙烯、丙酮、乙醇以及蒸餾水連續地進行超音波清潔5分鐘,儲存於異丙醇中並使用。 Transparent ITO electrode films obtained from glass used for OLED (manufactured by Samsung-Corning Co., Ltd.) were ultrasonically cleaned for 5 minutes each using trichloroethylene, acetone, ethanol, and distilled water, and then stored in isopropyl alcohol and used.

接下來,將ITO基板安裝在真空沉積器的基板夾中,且將以下4,4',4"-參(N,N-(2-萘基)-苯胺基)三苯胺(4,4’,4”-tris(N,N-(2-naphthyl)-phenylamino)triphenylamine)(2-TNATA)引入至真空沉積器中的區室中。 Next, the ITO substrate was mounted in the substrate holder of the vacuum depositor, and the following 4,4',4"-tris(N,N-(2-naphthyl)-phenylamino)triphenylamine (2-TNATA) was introduced into the chamber in the vacuum depositor.

Figure 107134589-A0305-02-0107-127
Figure 107134589-A0305-02-0107-127

隨後,將腔室抽真空直至腔室的真空度達至10-6托,且接著藉由施加電流至區室而蒸發2-TNATA,以在ITO基板上沉積厚度為600埃的電洞注入層。 Subsequently, the chamber was evacuated until the vacuum level of the chamber reached 10 -6 Torr, and then 2-TNATA was evaporated by applying a current to the chamber to deposit a hole injection layer with a thickness of 600 angstroms on the ITO substrate.

將以下N,N'-雙(α-萘基)-N,N'-二苯基-4,4'-二胺(NPB)引入至真空沉積器的另一區室,且藉由施加電流至區室使其蒸發,以在電洞注入層上沉積厚度為300埃的電洞轉移層。 The following N,N'-bis(α-naphthyl)-N,N'-diphenyl-4,4'-diamine (NPB) was introduced into another chamber of the vacuum deposition apparatus and evaporated by applying a current to the chamber to deposit a hole transfer layer with a thickness of 300 angstroms on the hole injection layer.

Figure 107134589-A0305-02-0107-128
Figure 107134589-A0305-02-0107-128

在如上形成電洞注入層及電洞轉移層之後,具有如下結構的發藍光材料沉積於其上作為發光層。具體言之,在真空沉積器中的一側區室中,真空沉積200埃厚度之H1(發藍光主體材料),且真空沉積相對於主體材料之5% D1(發藍光摻雜材料)於其上。 After the hole injection layer and the hole transfer layer are formed as above, a blue light-emitting material having the following structure is deposited thereon as a light-emitting layer. Specifically, in a side chamber of a vacuum depositor, H1 (blue light-emitting main material) with a thickness of 200 angstroms is vacuum deposited, and D1 (blue light-emitting doping material) with a thickness of 5% relative to the main material is vacuum deposited thereon.

Figure 107134589-A0305-02-0107-129
Figure 107134589-A0305-02-0107-129

隨後,沉積300埃厚度之表15中所描述之一種化合物作 為電子轉移層。 Subsequently, a compound described in Table 15 was deposited to a thickness of 300 angstroms as an electron transfer layer.

作為電子注入層,沉積10埃厚度的氟化鋰(LiF),且採用具有1,000埃厚度的Al陰極來製造OLED。 As an electron injection layer, lithium fluoride (LiF) is deposited to a thickness of 10 angstroms, and an Al cathode with a thickness of 1,000 angstroms is used to manufacture OLEDs.

同時,在10-6托至10-8托下藉由用於OLED製造之每種材料真空昇華純化所有製造OLED所需之有機化合物。 At the same time, all organic compounds required for OLED manufacturing are purified by vacuum sublimation of each material used for OLED manufacturing at 10 -6 to 10 -8 torr.

量測根據本發明製造的藍色有機發光裝置的驅動電壓、發光效率、色彩座標(CIE)以及壽命的結果如表15中所示。 The results of measuring the driving voltage, luminous efficiency, color coordinates (CIE) and life of the blue organic light-emitting device manufactured according to the present invention are shown in Table 15.

Figure 107134589-A0305-02-0108-130
Figure 107134589-A0305-02-0108-130
Figure 107134589-A0305-02-0109-131
Figure 107134589-A0305-02-0109-131
Figure 107134589-A0305-02-0110-132
Figure 107134589-A0305-02-0110-132
Figure 107134589-A0305-02-0111-134
Figure 107134589-A0305-02-0111-134

Figure 107134589-A0305-02-0111-135
Figure 107134589-A0305-02-0111-135

如表15之結果可見,與比較實例1相比,使用本發明之藍色有機發光裝置之電子轉移層材料的有機發光裝置具有較低驅動電壓,及顯著改良之發光效率以及壽命。 As shown in the results of Table 15, compared with Comparative Example 1, the organic light-emitting device using the electron transfer layer material of the blue organic light-emitting device of the present invention has a lower driving voltage and significantly improved light-emitting efficiency and life.

另外,識別出相較於比較實例2至比較實例4,發光效率及壽命更優良。特定言之,可見比較實例3及比較實例4之化合物B及化合物C具有經一個取代基取代的本申請案之核心結構。識別出,當經一個取代基取代時,相較於經本申請案之化學式1 之兩種類似的雜環化合物取代之化合物,熱穩定性降低且壽命異常地減少。 In addition, it is found that the luminous efficiency and life are better than those of Comparative Examples 2 to 4. Specifically, it can be seen that Compound B and Compound C of Comparative Examples 3 and 4 have the core structure of the present application substituted with one substituent. It is found that when substituted with one substituent, the thermal stability is reduced and the life is abnormally reduced compared to the compounds substituted with two similar heterocyclic compounds of Chemical Formula 1 of the present application.

<實驗實例2>製造有機發光裝置<Experimental Example 2> Manufacturing of an organic light-emitting device

1)製造有機發光裝置1) Manufacturing of organic light-emitting devices

將自用於OLED的玻璃(由三星康寧有限公司製造)獲得的透明ITO電極薄膜各自使用三氯乙烯、丙酮、乙醇以及蒸餾水連續地進行超音波清潔5分鐘,儲存於異丙醇中並使用。 Transparent ITO electrode films obtained from glass used for OLED (manufactured by Samsung Corning Co., Ltd.) were ultrasonically cleaned for 5 minutes each using trichloroethylene, acetone, ethanol, and distilled water, and then stored in isopropyl alcohol and used.

接下來,將ITO基板安裝在真空沉積器的基板夾中,且將以下4,4',4"-參(N,N-(2-萘基)-苯胺基)三苯胺(2-TNATA)引入至真空沉積器的區室中。 Next, the ITO substrate was mounted in the substrate holder of the vacuum depositor, and the following 4,4',4"-tris(N,N-(2-naphthyl)-anilino)triphenylamine (2-TNATA) was introduced into the chamber of the vacuum depositor.

Figure 107134589-A0305-02-0112-136
Figure 107134589-A0305-02-0112-136

隨後,將腔室抽真空直至腔室的真空度達至10-6托,且接著藉由施加電流至區室而蒸發2-TNATA,以在ITO基板上沉積厚度為600埃的電洞注入層。 Subsequently, the chamber was evacuated until the vacuum level of the chamber reached 10 -6 Torr, and then 2-TNATA was evaporated by applying a current to the chamber to deposit a hole injection layer with a thickness of 600 angstroms on the ITO substrate.

將以下N,N'-雙(α-萘基)-N,N'-二苯基-4,4'-二胺(NPB)引入至真空沉積器的另一區室,且藉由施加電流至區室使其蒸發,以在電洞注入層上沉積厚度為300埃的電洞轉移層。 The following N,N'-bis(α-naphthyl)-N,N'-diphenyl-4,4'-diamine (NPB) was introduced into another chamber of the vacuum deposition apparatus and evaporated by applying a current to the chamber to deposit a hole transfer layer with a thickness of 300 angstroms on the hole injection layer.

Figure 107134589-A0305-02-0113-137
Figure 107134589-A0305-02-0113-137

在如上形成電洞注入層及電洞轉移層之後,具有如下結構的發藍光材料沉積於其上作為發光層。具體言之,在真空沉積器中的一側區室中,真空沉積200埃厚度之H1(發藍光主體材料),且真空沉積相對於主體材料之5% D1(發藍光摻雜材料)於其上。 After the hole injection layer and the hole transfer layer are formed as above, a blue light-emitting material having the following structure is deposited thereon as a light-emitting layer. Specifically, in a side chamber of a vacuum depositor, H1 (blue light-emitting main material) with a thickness of 200 angstroms is vacuum deposited, and D1 (blue light-emitting doping material) with a thickness of 5% relative to the main material is vacuum deposited thereon.

Figure 107134589-A0305-02-0113-138
Figure 107134589-A0305-02-0113-138

隨後,沉積300埃厚度之以下結構式E1之化合物作為電子轉移層。 Subsequently, a compound of the following structural formula E1 is deposited to a thickness of 300 angstroms as an electron transfer layer.

Figure 107134589-A0305-02-0113-139
Figure 107134589-A0305-02-0113-139

作為電子注入層,沉積10埃厚度的氟化鋰(LiF),且採用具有1,000埃厚度的Al陰極來製造OLED。 As an electron injection layer, lithium fluoride (LiF) is deposited to a thickness of 10 angstroms, and an Al cathode with a thickness of 1,000 angstroms is used to manufacture OLEDs.

同時,在10-6托至10-8托下藉由用於OLED製造之每種材料真空昇華純化所有製造OLED所需之有機化合物。 At the same time, all organic compounds required for OLED manufacturing are purified by vacuum sublimation of each material used for OLED manufacturing at 10 -6 to 10 -8 torr.

除在形成250埃厚度的上述結構式E1之化合物作為電子轉移層之後,使用下表16中呈現的化合物在電子轉移層上形成50埃厚度的電洞阻擋層以外,以與實驗實例2中相同的方式製造電致發光裝置。 The electroluminescent device was manufactured in the same manner as in Experimental Example 2, except that after forming a 250 angstrom thick compound of the above structural formula E1 as an electron transfer layer, a 50 angstrom thick hole blocking layer was formed on the electron transfer layer using the compound presented in Table 16 below.

量測根據本發明製造的藍色有機發光裝置的驅動電壓、發光效率、色彩座標(CIE)以及壽命的結果如表16中所示。 The results of measuring the driving voltage, luminous efficiency, color coordinates (CIE) and life of the blue organic light-emitting device manufactured according to the present invention are shown in Table 16.

Figure 107134589-A0305-02-0114-140
Figure 107134589-A0305-02-0114-140

如表16之結果可見,與比較實例5相比,使用本發明之藍色有機發光裝置之電洞阻擋層材料的有機發光裝置具有較低驅動電壓,及顯著改良之發光效率及壽命。另外,相較於比較實例6至比較實例8,光發射效率及壽命顯著改良。特定言之,可見比較實例7及比較實例8之化合物B及化合物C具有經一個取代基取 代的本申請案之核心結構。識別出,當經一個取代基取代時,相較於經本申請案之化學式1之兩種類似的雜環化合物取代之化合物,熱穩定性降低且壽命異常地減少。 As shown in the results of Table 16, compared with Comparative Example 5, the organic light-emitting device using the hole blocking layer material of the blue organic light-emitting device of the present invention has a lower driving voltage, and significantly improved light-emitting efficiency and life. In addition, compared with Comparative Examples 6 to 8, the light emission efficiency and life are significantly improved. Specifically, it can be seen that Compound B and Compound C of Comparative Examples 7 and 8 have the core structure of the present application substituted with one substituent. It is identified that when substituted with one substituent, the thermal stability is reduced and the life is abnormally reduced compared to the compounds substituted with two similar heterocyclic compounds of Chemical Formula 1 of the present application.

這一原因是由於本申請案之化學式1之化合物為具有p型及n型之雙極類型,且能夠阻斷電洞洩漏及有效捕獲發光層中之激子。 This is because the compound of Chemical Formula 1 in the present application is a bipolar type with p-type and n-type properties, and is able to block hole leakage and effectively capture excitons in the light-emitting layer.

<實驗實例3>製造有機發光裝置<Experimental Example 3> Manufacturing of an organic light-emitting device

1)製造有機發光裝置1) Manufacturing of organic light-emitting devices

用蒸餾水超音波清潔玻璃基板,ITO作為薄膜以1500埃之厚度塗佈於所述玻璃基板上。用蒸餾水清潔結束後,用溶劑(諸如丙酮、甲醇以及異丙醇)超音波清潔基板,接著乾燥,且在使用UV之UV清潔器中進行UVO處理5分鐘。此後,將基板轉移至電漿清潔器(PT),且在真空下進行電漿處理以便移除ITO功函數以及剩餘薄膜,且將基板轉移至熱沉積設備以用於有機沉積。 The glass substrate was ultrasonically cleaned with distilled water, and ITO was coated as a thin film with a thickness of 1500 angstroms on the glass substrate. After cleaning with distilled water, the substrate was ultrasonically cleaned with a solvent (such as acetone, methanol, and isopropyl alcohol), then dried, and UVO treated for 5 minutes in a UV cleaner using UV. Thereafter, the substrate was transferred to a plasma cleaner (PT) and plasma treated under vacuum to remove the ITO work function and residual film, and the substrate was transferred to a thermal deposition equipment for organic deposition.

在透明ITO電極(陽極)上,有機材料形成於2堆疊白色有機發光裝置(white organic light emitting device;WOLED)結構中。對於第一堆疊,將TAPC熱真空沉積至300埃厚度以首先形成電洞轉移層。形成電洞轉移層後,將發光層如下熱真空沉積於其上。藉由將FIrpic作為藍色磷光摻雜劑摻雜8%至TCz1(主體)而沉積300埃之發光層。在使用TmPyPB形成400埃的電子轉移層之後,藉由將Cs2CO3摻雜20%至下表17中所列的化合物形成100埃的電荷產生層。 On a transparent ITO electrode (anode), organic materials are formed in a 2-stack white organic light emitting device (WOLED) structure. For the first stack, TAPC is thermally vacuum deposited to a thickness of 300 angstroms to first form a hole transfer layer. After forming the hole transfer layer, the light emitting layer is thermally vacuum deposited thereon as follows. A 300 angstrom light emitting layer is deposited by doping 8% of FIrpic as a blue phosphorescent dopant into TCz1 (host). After forming a 400 angstrom electron transfer layer using TmPyPB, a 100 angstrom charge generation layer is formed by doping 20% of Cs 2 CO 3 into the compounds listed in Table 17 below.

對於第二堆疊,首先將MoO3熱真空沉積至50埃厚度以形成電洞注入層。藉由將MoO3摻雜20%至TAPC至100埃且將 TAPC沉積至300埃來形成電洞轉移層(常用層)。藉由將Ir(ppy)3(綠色磷光摻雜劑)摻雜8%至TCz1(主體)而於其上沉積300埃的發光層,且使用TmPyPB形成600埃的電子轉移層。最後,藉由沉積10埃厚度氟化鋰(LiF),使電子注入層形成於電子轉移層上,且接著藉由沉積1,200埃厚度的鋁(Al)陰極,使陰極形成於電子注入層上,從而製造有機發光裝置。 For the second stack, MoO3 was first thermally vacuum deposited to a thickness of 50 angstroms to form a hole injection layer. A hole transfer layer (common layer) was formed by doping MoO3 20% with TAPC to 100 angstroms and depositing TAPC to 300 angstroms. A luminescent layer of 300 angstroms was deposited on TCz1 (host) by doping Ir(ppy) 3 (green phosphorescent dopant) 8% and an electron transfer layer of 600 angstroms was formed using TmPyPB. Finally, an electron injection layer is formed on the electron transfer layer by depositing lithium fluoride (LiF) to a thickness of 10 angstroms, and then an aluminum (Al) cathode is formed on the electron injection layer by depositing a thickness of 1,200 angstroms, thereby manufacturing an organic light-emitting device.

同時,在10-6托至10-8托下藉由用於OLED製造之每種材料真空昇華純化所有製造OLED所需之有機化合物。 At the same time, all organic compounds required for OLED manufacturing are purified by vacuum sublimation of each material used for OLED manufacturing at 10 -6 to 10 -8 torr.

Figure 107134589-A0305-02-0116-141
Figure 107134589-A0305-02-0116-141

量測根據本發明製造的白色有機發光裝置的驅動電壓、發光效率、色彩座標(CIE)以及壽命(T95)的結果如下表17中所示。 The results of measuring the driving voltage, luminous efficiency, color coordinates (CIE) and life (T95) of the white organic light-emitting device manufactured according to the present invention are shown in Table 17 below.

Figure 107134589-A0305-02-0116-142
Figure 107134589-A0305-02-0116-142
Figure 107134589-A0305-02-0117-143
Figure 107134589-A0305-02-0117-143

如表17之結果可見,與比較實例9至比較實例11相比,使用本發明之2-堆疊白色有機發光裝置之電荷產生層材料的有機發光裝置具有較低驅動電壓及經改良之發光效率。另外,相較於比較實例12至比較實例14,驅動電壓類似,但發光效率及壽命顯著改良。 As shown in the results of Table 17, compared with Comparative Examples 9 to 11, the organic light-emitting device using the charge generation layer material of the 2-stacked white organic light-emitting device of the present invention has a lower driving voltage and improved luminous efficiency. In addition, compared with Comparative Examples 12 to 14, the driving voltage is similar, but the luminous efficiency and life are significantly improved.

特定言之,可見比較實例13及比較實例14之化合物B及化合物C具有經一個取代基取代的本申請案之核心結構。識別出,當經一個取代基取代時,相較於經本申請案之化學式1之兩種類似的雜環化合物取代之化合物,熱穩定性降低且壽命異常地減少。 Specifically, it can be seen that Compound B and Compound C of Comparative Example 13 and Comparative Example 14 have the core structure of the present application substituted with one substituent. It is recognized that when substituted with one substituent, the thermal stability is reduced and the lifespan is abnormally reduced compared to the compounds substituted with two similar heterocyclic compounds of Chemical Formula 1 of the present application.

Figure 107134589-A0305-02-0002-3
Figure 107134589-A0305-02-0003-4
Figure 107134589-A0305-02-0002-3
Figure 107134589-A0305-02-0003-4

100:基板 100: Substrate

200:陽極 200: Yang pole

300:有機材料層 300: Organic material layer

400:陰極 400: cathode

Claims (14)

一種雜環化合物,由以下化學式2至化學式9中的任一者表示:
Figure 107134589-A0305-02-0119-144
Figure 107134589-A0305-02-0119-145
Figure 107134589-A0305-02-0119-146
[化學式5]
Figure 107134589-A0305-02-0120-147
Figure 107134589-A0305-02-0120-148
Figure 107134589-A0305-02-0120-149
[化學式8]
Figure 107134589-A0305-02-0121-150
Figure 107134589-A0305-02-0121-151
其中,在化學式2至化學式9中,R2至R5彼此相同或不同,且各自獨立地是由下列各者所構成的族群中選出:氫、氘、鹵基、-CN、經取代或未經取代之烷基、經取代或未經取代之烯基、經取代或未經取代之炔基、經取代或未經取代之烷氧基、經取代或未經取代之環烷基、經取代或未經取代之雜環烷基、經取代或未經取代之芳基、經取代或未經取代之雜芳基、-SiRR'R"、-P(=O)RR'以及胺基,所述胺基未經取代或經以下取代:經取代或未經取代之烷基、經取代或未經取代之芳基或者經取代或未經取代之雜芳基; Ra為氫;經取代或未經取代的烷基;經取代或未經取代的芳基;或者經取代或未經取代的雜芳基,Ar1由(L1)p-(Z1)q表示;Ar2由-(L2)r-(Z2)s表示;L1及L2彼此相同或不同,且各自獨立地為經取代或未經取代之伸芳基;或者經取代或未經取代之伸雜芳基;Z1及Z2彼此相同或不同,且各自獨立地是由下列各者所構成的族群中選出:氫、氘、鹵基、-CN、經取代或未經取代之烷基、經取代或未經取代之烯基、經取代或未經取代之炔基、經取代或未經取代之烷氧基、經取代或未經取代之環烷基、經取代或未經取代之雜環烷基、經取代或未經取代之芳基、經取代或未經取代之雜芳基、-SiRR'R"、-P(=O)RR'以及胺基,所述胺基未經取代或經以下取代:經取代或未經取代之烷基、經取代或未經取代之芳基或者經取代或未經取代之雜芳基;R、R'及R"彼此相同或不同,且各自獨立地為氫、氘、-CN、經取代或未經取代之烷基、經取代或未經取代之環烷基、經取代或未經取代之芳基或者經取代或未經取代之雜芳基;p及r為1至4之整數;q及s為1至3之整數;以及n為0至4之整數。
A heterocyclic compound represented by any one of the following Chemical Formulas 2 to 9:
Figure 107134589-A0305-02-0119-144
Figure 107134589-A0305-02-0119-145
Figure 107134589-A0305-02-0119-146
[Chemical formula 5]
Figure 107134589-A0305-02-0120-147
Figure 107134589-A0305-02-0120-148
Figure 107134589-A0305-02-0120-149
[Chemical formula 8]
Figure 107134589-A0305-02-0121-150
Figure 107134589-A0305-02-0121-151
Wherein, in Chemical Formulae 2 to 9, R2 to R5 are the same or different from each other, and are independently selected from the group consisting of: hydrogen, deuterium, halogen, -CN, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, -SiRR'R", -P(=O)RR', and amino, wherein the amino is unsubstituted or substituted with: substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; Ra is hydrogen; substituted or unsubstituted alkyl; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl; Ar1 is represented by (L1)p-(Z1)q; Ar2 is represented by -(L2)r-(Z2)s; L1 and L2 are the same or different and are each independently a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group; Z1 and Z2 are the same or different and are each independently selected from the group consisting of hydrogen, deuterium, halogen, -CN, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, a substituted or unsubstituted heteroaryl group, -SiRR'R", -P(=O)RR' and an amine group, wherein the amine group is unsubstituted or substituted with a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group; R, R' and R" are the same as or different from each other and are each independently hydrogen, deuterium, -CN, a substituted or unsubstituted alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group; p and r are integers from 1 to 4; q and s are integers from 1 to 3; and n is an integer from 0 to 4.
如申請專利範圍第1項所述的雜環化合物,其中所述「經取代或未經取代」意謂經由下列各者所構成的族群中選出的一或多個取代基取代:C1至C60直鏈或分支鏈烷基、C2至C60直鏈或分支鏈烯基、C2至C60直鏈或分支鏈炔基、C3至C60單環 或多環環烷基、C2至C60單環或多環雜環烷基、C6至C60單環或多環芳基、C2至C60單環或多環雜芳基、-SiRR'R"、-P(=O)RR'、C1至C20烷胺、C6至C60單環或多環芳胺以及C2至C60單環或多環雜芳胺,或未經取代,或者經連接由以上示出之所述取代基中選出之兩個或更多個取代基的取代基取代,或未經取代;以及R、R'以及R"之定義與化學式2至9中相同。 The heterocyclic compound as described in claim 1, wherein the term "substituted or unsubstituted" means substituted by one or more substituents selected from the group consisting of: C1 to C60 straight chain or branched chain alkyl, C2 to C60 straight chain or branched chain alkenyl, C2 to C60 straight chain or branched chain alkynyl, C3 to C60 monocyclic or polycyclic cycloalkyl, C2 to C60 monocyclic or polycyclic heterocyclic alkyl, C6 to C60 monocyclic or polycyclic Aryl, C2 to C60 monocyclic or polycyclic heteroaryl, -SiRR'R", -P(=O)RR', C1 to C20 alkylamine, C6 to C60 monocyclic or polycyclic aromatic amine and C2 to C60 monocyclic or polycyclic heteroaryl amine, or unsubstituted, or substituted by two or more substituents selected from the substituents shown above, or unsubstituted; and R, R' and R" are defined the same as in Chemical Formulas 2 to 9. 如申請專利範圍第1項所述的雜環化合物,其中R2至R5為氫。 The heterocyclic compound as described in claim 1, wherein R 2 to R 5 are hydrogen. 如申請專利範圍第1項所述的雜環化合物,其中L1及L2彼此相同或不同,且各自獨立地為C6至C40伸芳基;或C2至C40伸雜芳基,Z1及Z2彼此相同或不同,且各自獨立地為氫;經取代或未經取代之C6至C40芳基;經取代或未經取代之C2至C40雜芳基;或P(=O)RR',且R及R'之定義與化學式2至9中相同。 The heterocyclic compound as described in item 1 of the patent application, wherein L1 and L2 are the same or different and are independently C6 to C40 aryl groups; or C2 to C40 heteroaryl groups, Z1 and Z2 are the same or different and are independently hydrogen; substituted or unsubstituted C6 to C40 aryl groups; substituted or unsubstituted C2 to C40 heteroaryl groups; or P(=O)RR', and the definitions of R and R' are the same as those in chemical formulas 2 to 9. 如申請專利範圍第1項所述的雜環化合物,其中Ra為氫。 A heterocyclic compound as described in item 1 of the patent application, wherein Ra is hydrogen. 如申請專利範圍第1項所述的雜環化合物,其中化學式2至9由以下化合物中之任一者表示:
Figure 107134589-A0305-02-0124-152
Figure 107134589-A0305-02-0125-154
Figure 107134589-A0305-02-0126-157
Figure 107134589-A0305-02-0127-163
Figure 107134589-A0305-02-0128-164
Figure 107134589-A0305-02-0129-165
Figure 107134589-A0305-02-0130-167
Figure 107134589-A0305-02-0131-168
Figure 107134589-A0305-02-0132-170
Figure 107134589-A0305-02-0133-173
Figure 107134589-A0305-02-0134-174
Figure 107134589-A0305-02-0135-175
Figure 107134589-A0305-02-0136-177
Figure 107134589-A0305-02-0137-178
Figure 107134589-A0305-02-0138-180
Figure 107134589-A0305-02-0139-181
Figure 107134589-A0305-02-0140-184
Figure 107134589-A0305-02-0141-185
Figure 107134589-A0305-02-0142-187
Figure 107134589-A0305-02-0143-188
Figure 107134589-A0305-02-0144-190
The heterocyclic compound as described in claim 1, wherein chemical formulas 2 to 9 are represented by any one of the following compounds:
Figure 107134589-A0305-02-0124-152
Figure 107134589-A0305-02-0125-154
Figure 107134589-A0305-02-0126-157
Figure 107134589-A0305-02-0127-163
Figure 107134589-A0305-02-0128-164
Figure 107134589-A0305-02-0129-165
Figure 107134589-A0305-02-0130-167
Figure 107134589-A0305-02-0131-168
Figure 107134589-A0305-02-0132-170
Figure 107134589-A0305-02-0133-173
Figure 107134589-A0305-02-0134-174
Figure 107134589-A0305-02-0135-175
Figure 107134589-A0305-02-0136-177
Figure 107134589-A0305-02-0137-178
Figure 107134589-A0305-02-0138-180
Figure 107134589-A0305-02-0139-181
Figure 107134589-A0305-02-0140-184
Figure 107134589-A0305-02-0141-185
Figure 107134589-A0305-02-0142-187
Figure 107134589-A0305-02-0143-188
Figure 107134589-A0305-02-0144-190
一種有機發光裝置,包括:第一電極; 第二電極,設置為與所述第一電極相對;以及一或多個有機材料層,設置於所述第一電極與所述第二電極之間,其中所述有機材料層之一或多個層包括如申請專利範圍第1項至第6項中任一項所述的雜環化合物。 An organic light-emitting device comprises: a first electrode; a second electrode disposed opposite to the first electrode; and one or more organic material layers disposed between the first electrode and the second electrode, wherein one or more of the organic material layers comprises a heterocyclic compound as described in any one of items 1 to 6 of the patent application scope. 如申請專利範圍第7項所述的有機發光裝置,其中所述有機材料層包括發光層,且所述發光層包括所述雜環化合物。 An organic light-emitting device as described in Item 7 of the patent application, wherein the organic material layer includes a light-emitting layer, and the light-emitting layer includes the heterocyclic compound. 如申請專利範圍第7項所述的有機發光裝置,其中所述有機材料層包括電子注入層或電子轉移層,且所述電子注入層或所述電子轉移層包括所述雜環化合物。 An organic light-emitting device as described in Item 7 of the patent application, wherein the organic material layer includes an electron injection layer or an electron transfer layer, and the electron injection layer or the electron transfer layer includes the heterocyclic compound. 如申請專利範圍第7項所述的有機發光裝置,其中所述有機材料層包括電子阻擋層或電洞阻擋層,且所述電子阻擋層或所述電洞阻擋層包括所述雜環化合物。 An organic light-emitting device as described in Item 7 of the patent application, wherein the organic material layer includes an electron blocking layer or a hole blocking layer, and the electron blocking layer or the hole blocking layer includes the heterocyclic compound. 如申請專利範圍第7項所述的有機發光裝置,更包括由下列各者所構成的族群中選出的一個層、兩個層或更多個層:發光層、電洞注入層、電洞轉移層、電子注入層、電子轉移層、電子阻擋層以及電洞阻擋層。 The organic light-emitting device as described in Item 7 of the patent application further includes one layer, two layers or more layers selected from the group consisting of the following: a light-emitting layer, a hole injection layer, a hole transfer layer, an electron injection layer, an electron transfer layer, an electron blocking layer and a hole blocking layer. 如申請專利範圍第7項所述的有機發光裝置,包括:第一電極;第一堆疊,設置於所述第一電極上且包括第一發光層;電荷產生層,設置於所述第一堆疊上;第二堆疊,設置於所述電荷產生層上且包括第二發光層;以及第二電極,設置於所述第二堆疊上。 The organic light-emitting device as described in item 7 of the patent application scope comprises: a first electrode; a first stack disposed on the first electrode and comprising a first light-emitting layer; a charge generating layer disposed on the first stack; a second stack disposed on the charge generating layer and comprising a second light-emitting layer; and a second electrode disposed on the second stack. 如申請專利範圍第12項所述的有機發光裝置,其中所述電荷產生層包括所述雜環化合物。 An organic light-emitting device as described in claim 12, wherein the charge generating layer includes the heterocyclic compound. 如申請專利範圍第12項所述的有機發光裝置,其中所述電荷產生層為N型電荷產生層,且所述電荷產生層包括所述雜環化合物。 An organic light-emitting device as described in item 12 of the patent application, wherein the charge generating layer is an N-type charge generating layer, and the charge generating layer includes the heterocyclic compound.
TW107134589A 2018-10-01 2018-10-01 Heterocyclic compound and organic light emitting device comprising the same TWI856950B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW107134589A TWI856950B (en) 2018-10-01 2018-10-01 Heterocyclic compound and organic light emitting device comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW107134589A TWI856950B (en) 2018-10-01 2018-10-01 Heterocyclic compound and organic light emitting device comprising the same

Publications (2)

Publication Number Publication Date
TW202024299A TW202024299A (en) 2020-07-01
TWI856950B true TWI856950B (en) 2024-10-01

Family

ID=73004950

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107134589A TWI856950B (en) 2018-10-01 2018-10-01 Heterocyclic compound and organic light emitting device comprising the same

Country Status (1)

Country Link
TW (1) TWI856950B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1723258A (en) * 2002-12-12 2006-01-18 出光兴产株式会社 Organic electroluminescent device material and organic electroluminescent device using the same
US20150325799A1 (en) * 2014-05-07 2015-11-12 Samsung Electronics Co., Ltd. Condensed cyclic compound and organic light-emitting device including the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1723258A (en) * 2002-12-12 2006-01-18 出光兴产株式会社 Organic electroluminescent device material and organic electroluminescent device using the same
US20150325799A1 (en) * 2014-05-07 2015-11-12 Samsung Electronics Co., Ltd. Condensed cyclic compound and organic light-emitting device including the same

Also Published As

Publication number Publication date
TW202024299A (en) 2020-07-01

Similar Documents

Publication Publication Date Title
TWI811551B (en) Hetero-cyclic compound and organic light emitting device using the same
TWI842818B (en) Compound, organic optoelectronic diode and display device
TW201829404A (en) Heterocyclic compound and organic light-emitting device using the same
TW202000861A (en) Heterocyclic compound, organic light emitting device comprising the same,manufacturing method of the same and composition for organic material layer of organic light emitting device
TWI775957B (en) Heterocyclic compound and organic light emitting device comprising the same
TWI873209B (en) Heterocyclic compound and organic light emitting device comprising the same
TWI857103B (en) Heterocyclic compound and organic light emitting device comprising the same
TW202130640A (en) Heterocyclic compound and organic light emitting device including the same
TW202132536A (en) Heterocyclic compound and organic light emitting device comprising same
TW202005954A (en) Heterocyclic compound, organic lightemitting device and method formanufacturing the same, and compositionfor organic material layer of organiclight emitting device
TW202219041A (en) Heterocyclic compound and organic light emitting device comprising the same
JP7421802B2 (en) Heterocyclic compounds and organic light-emitting devices containing them
TWI838619B (en) Heterocyclic compound and organic light emitting device comprising the same
TWI809222B (en) Heterocyclic compound and organic light emitting device comprising the same
TW202130784A (en) Heterocyclic compound and organic light emitting device comprising same
KR102374517B1 (en) Heterocyclic compound and organic light emitting device comprising the same
TWI804701B (en) Compounds, organic optoelectronic diode, and display device
TW202124357A (en) Heterocyclic compound and organic light emitting device comprising the same
TWI811251B (en) Hetero-cyclic compound and organic light emitting device using the same
TW202024094A (en) Heterocyclic compound and organic light emitting device comprising same
TWI861186B (en) Heterocyclic compound and organic light emitting device using the same
TWI733253B (en) Heterocyclic compound and organic light emitting device comprising the same
CN112969705B (en) Heterocyclic compound and organic light-emitting device containing the compound
JP7040817B2 (en) Heterocyclic compounds and organic light emitting devices containing them
TWI856950B (en) Heterocyclic compound and organic light emitting device comprising the same